00013147272025Q1False9/27http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent9P1YP1YP1Yiso4217:USDxbrli:sharesxbrli:sharesiso4217:USDsono:countryxbrli:puresono:patentsono:complaintsono:lawsuit00013147272024-09-292024-12-2800013147272024-09-2800013147272024-12-2800013147272025-01-2500013147272023-10-012023-12-3000013147272023-09-300001314727us-gaap:CommonStockMember2024-09-280001314727us-gaap:CommonStockMember2023-09-300001314727us-gaap:CommonStockMember2024-09-292024-12-280001314727us-gaap:CommonStockMember2023-10-012023-12-300001314727us-gaap:CommonStockMember2024-12-280001314727us-gaap:CommonStockMember2023-12-300001314727us-gaap:AdditionalPaidInCapitalMember2024-09-280001314727us-gaap:AdditionalPaidInCapitalMember2023-09-300001314727us-gaap:AdditionalPaidInCapitalMember2024-09-292024-12-280001314727us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-300001314727us-gaap:AdditionalPaidInCapitalMember2024-12-280001314727us-gaap:AdditionalPaidInCapitalMember2023-12-300001314727us-gaap:TreasuryStockCommonMember2024-09-280001314727us-gaap:TreasuryStockCommonMember2023-09-300001314727us-gaap:TreasuryStockCommonMember2024-09-292024-12-280001314727us-gaap:TreasuryStockCommonMember2023-10-012023-12-300001314727us-gaap:TreasuryStockCommonMember2024-12-280001314727us-gaap:TreasuryStockCommonMember2023-12-300001314727us-gaap:RetainedEarningsMember2024-09-280001314727us-gaap:RetainedEarningsMember2023-09-300001314727us-gaap:RetainedEarningsMember2024-09-292024-12-280001314727us-gaap:RetainedEarningsMember2023-10-012023-12-300001314727us-gaap:RetainedEarningsMember2024-12-280001314727us-gaap:RetainedEarningsMember2023-12-300001314727us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-280001314727us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001314727us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-292024-12-280001314727us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-300001314727us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-280001314727us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3000013147272023-12-300001314727us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2024-12-280001314727us-gaap:FairValueInputsLevel1Member2024-12-280001314727us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2024-12-280001314727us-gaap:FairValueInputsLevel2Member2024-12-280001314727us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-12-300001314727us-gaap:FairValueInputsLevel1Member2023-12-300001314727us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2023-12-300001314727us-gaap:FairValueInputsLevel2Member2023-12-300001314727sono:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrentMember2024-09-280001314727srt:AmericasMember2024-09-292024-12-280001314727srt:AmericasMember2023-10-012023-12-300001314727us-gaap:EMEAMember2024-09-292024-12-280001314727us-gaap:EMEAMember2023-10-012023-12-300001314727srt:AsiaPacificMember2024-09-292024-12-280001314727srt:AsiaPacificMember2023-10-012023-12-300001314727country:US2024-09-292024-12-280001314727country:US2023-10-012023-12-300001314727us-gaap:NonUsMember2024-09-292024-12-280001314727us-gaap:NonUsMember2023-10-012023-12-300001314727sono:SonosSpeakersMember2024-09-292024-12-280001314727sono:SonosSpeakersMember2023-10-012023-12-300001314727sono:SonosSystemProductsMember2024-09-292024-12-280001314727sono:SonosSystemProductsMember2023-10-012023-12-300001314727sono:PartnerProductsAndOtherRevenueMember2024-09-292024-12-280001314727sono:PartnerProductsAndOtherRevenueMember2023-10-012023-12-3000013147272023-10-012024-09-280001314727sono:MayhtHoldingBvMemberus-gaap:InProcessResearchAndDevelopmentMember2024-09-292024-12-280001314727sono:MayhtHoldingBvMemberus-gaap:InProcessResearchAndDevelopmentMember2024-09-292024-12-280001314727sono:MayhtHoldingBvMemberus-gaap:InProcessResearchAndDevelopmentMember2024-12-280001314727us-gaap:TradeNamesMember2024-12-280001314727us-gaap:TradeNamesMember2024-09-292024-12-280001314727us-gaap:TechnologyBasedIntangibleAssetsMember2024-12-280001314727us-gaap:TechnologyBasedIntangibleAssetsMember2024-09-292024-12-280001314727us-gaap:TradeNamesMember2024-09-280001314727us-gaap:TradeNamesMember2023-10-012024-09-280001314727us-gaap:TechnologyBasedIntangibleAssetsMember2024-09-280001314727us-gaap:TechnologyBasedIntangibleAssetsMember2023-10-012024-09-280001314727us-gaap:InProcessResearchAndDevelopmentMember2024-09-2800013147272024-12-292024-12-2800013147272025-09-292024-12-2800013147272026-10-042024-12-2800013147272027-10-032024-12-2800013147272028-10-012024-12-280001314727us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-10-132021-10-130001314727us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-10-130001314727us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:BaseRateMember2023-06-012023-06-300001314727us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2023-06-012023-06-300001314727us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2023-06-012023-06-300001314727us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2021-10-132021-10-130001314727us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2021-10-132021-10-130001314727us-gaap:LetterOfCreditMemberus-gaap:LineOfCreditMember2024-12-280001314727us-gaap:PurchaseCommitmentMember2024-12-280001314727us-gaap:PurchaseCommitmentMember2024-09-292024-12-280001314727srt:MinimumMemberus-gaap:SupplyCommitmentMember2024-12-280001314727srt:MaximumMemberus-gaap:SupplyCommitmentMember2024-12-280001314727us-gaap:SupplyCommitmentMember2024-09-292024-12-280001314727sono:LawsuitsAgainstGoogleMember2022-01-012022-01-310001314727sono:LawsuitsAgainstGoogleMember2024-05-012024-05-310001314727sono:GoogleLawsuitsAgainstSonosMember2020-06-112020-06-110001314727sono:GoogleLawsuitsAgainstSonosMember2022-08-080001314727sono:GoogleLawsuitsAgainstSonosMember2022-08-082022-08-080001314727sono:ImplicitAgainstSonosMember2017-03-102017-03-1000013147272023-11-150001314727us-gaap:RestrictedStockUnitsRSUMember2024-09-280001314727us-gaap:RestrictedStockUnitsRSUMember2024-09-292024-12-280001314727us-gaap:RestrictedStockUnitsRSUMember2024-12-280001314727us-gaap:RestrictedStockUnitsRSUMember2023-10-012024-06-290001314727us-gaap:PerformanceSharesMember2024-09-280001314727us-gaap:PerformanceSharesMember2024-09-292024-12-280001314727us-gaap:PerformanceSharesMember2024-12-280001314727us-gaap:PerformanceSharesMember2023-10-012024-06-290001314727us-gaap:CostOfSalesMember2024-09-292024-12-280001314727us-gaap:CostOfSalesMember2023-10-012023-12-300001314727us-gaap:ResearchAndDevelopmentExpenseMember2024-09-292024-12-280001314727us-gaap:ResearchAndDevelopmentExpenseMember2023-10-012023-12-300001314727us-gaap:SellingAndMarketingExpenseMember2024-09-292024-12-280001314727us-gaap:SellingAndMarketingExpenseMember2023-10-012023-12-300001314727us-gaap:GeneralAndAdministrativeExpenseMember2024-09-292024-12-280001314727us-gaap:GeneralAndAdministrativeExpenseMember2023-10-012023-12-300001314727us-gaap:EmployeeStockOptionMember2024-09-292024-12-280001314727us-gaap:EmployeeStockOptionMember2023-10-012023-12-300001314727us-gaap:RestrictedStockUnitsRSUMember2024-09-292024-12-280001314727us-gaap:RestrictedStockUnitsRSUMember2023-10-012023-12-300001314727us-gaap:PerformanceSharesMember2024-09-292024-12-280001314727us-gaap:PerformanceSharesMember2023-10-012023-12-300001314727us-gaap:EmployeeStockOptionMember2024-09-292024-12-280001314727us-gaap:EmployeeStockOptionMember2023-10-012023-12-300001314727us-gaap:RestrictedStockUnitsRSUMember2024-09-292024-12-280001314727us-gaap:RestrictedStockUnitsRSUMember2023-10-012023-12-300001314727us-gaap:PerformanceSharesMember2024-09-292024-12-280001314727us-gaap:PerformanceSharesMember2023-10-012023-12-300001314727us-gaap:SubsequentEventMember2025-02-052025-02-050001314727us-gaap:SubsequentEventMembersrt:MinimumMember2025-02-050001314727us-gaap:SubsequentEventMembersrt:MaximumMember2025-02-050001314727sono:JoannaColesMember2024-09-292024-12-280001314727sono:JoannaColesMember2024-12-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 28, 2024
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from       to
Commission File Number: 001-38603
_________________________________________________________
SONOS, INC.
(Exact name of registrant as specified in its charter)
_________________________________________________________
Delaware03-0479476
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
301 Coromar DriveSanta BarbaraCA93117
(Address of Principal Executive Offices)(Zip Code)
(805) 965-3001
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value
SONO
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  x  No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
xAccelerated filero
Non-accelerated fileroSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  o  No x
As of January 25, 2025, the registrant had 119,082,663 shares of common stock outstanding.


TABLE OF CONTENTS
Page


PART I. FINANCIAL INFORMATION
Item 1.     Financial statements
SONOS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par values)
As of
December 28,
2024
September 28,
2024
Assets
Current assets:
Cash and cash equivalents$279,955 $169,732 
Marketable securities47,902 51,426 
Accounts receivable, net84,786 44,513 
Inventories140,892 231,505 
Prepaids and other current assets58,991 53,910 
Total current assets612,526 551,086 
Property and equipment, net95,028 102,148 
Operating lease right-of-use assets47,935 50,175 
Goodwill82,854 82,854 
Intangible assets, net
In-process research and development 73,770 
Other intangible assets84,488 14,266 
Deferred tax assets9,654 10,314 
Other noncurrent assets31,120 31,699 
Total assets$963,605 $916,312 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$162,080 $194,590 
Accrued expenses108,871 87,783 
Accrued compensation28,509 15,701 
Deferred revenue, current20,973 21,802 
Other current liabilities52,081 46,277 
Total current liabilities372,514 366,153 
Operating lease liabilities, noncurrent56,786 56,588 
Deferred revenue, noncurrent61,245 61,075 
Deferred tax liabilities176 60 
Other noncurrent liabilities3,757 3,816 
Total liabilities494,478 487,692 
Commitments and contingencies (Note 7)
Stockholders’ equity:
Common stock, $0.001 par value
125 123 
Treasury stock(48,504)(17,096)
Additional paid-in capital521,121 498,245 
Accumulated deficit
(697)(50,934)
Accumulated other comprehensive loss(2,918)(1,718)
Total stockholders’ equity469,127 428,620 
Total liabilities and stockholders’ equity$963,605 $916,312 
The accompanying notes are an integral part of these condensed consolidated financial statements.
3

SONOS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(unaudited, in thousands, except share and per share amounts)
Three Months Ended
December 28,
2024
December 30,
2023
Revenue$550,857 $612,869 
Cost of revenue309,451 330,190 
Gross profit241,406 282,679 
Operating expenses
Research and development80,838 79,235 
Sales and marketing86,644 83,950 
General and administrative25,831 39,799 
Total operating expenses193,313 202,984 
Operating income
48,093 79,695 
Other income (expense), net
Interest income1,861 3,075 
Interest expense(110)(105)
Other income (expense), net(6,029)10,274 
Total other income (expense), net
(4,278)13,244 
Income before provision for (benefit from) income taxes
43,815 92,939 
Provision for (benefit from) income taxes
(6,422)11,992 
Net income
$50,237 $80,947 
Net income attributable to common stockholders:
Basic and diluted$50,237 $80,947 
Net income per share attributable to common stockholders:
Basic$0.41 $0.65 
Diluted$0.40 $0.64 
Weighted-average shares used in computing net income per share attributable to common stockholders:
Basic122,071,586125,181,717
Diluted124,731,619126,742,153
Total comprehensive income
Net income
50,237 80,947 
Change in foreign currency translation adjustment(1,116)(863)
Net unrealized loss on marketable securities (84) 
Comprehensive income
$49,037 $80,084 
The accompanying notes are an integral part of these condensed consolidated financial statements.
4

SONOS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(unaudited, in thousands, except share amounts)
Three Months Ended
December 28,
2024
December 30,
2023
Total stockholders' equity, beginning balances$428,620 $518,657 
Common stock
Beginning balances$123 $130 
Issuance of common stock pursuant to equity incentive plans2 1 
Retirement of treasury stock (4)
Ending balances$125 $127 
Additional paid-in capital
Beginning balances$498,245 $607,345 
Issuance of common stock pursuant to equity incentive plans2,409 3,537 
Retirement of treasury stock(4,867)(60,954)
Stock-based compensation expense25,334 19,358 
Ending balances$521,121 $569,286 
Treasury stock
Beginning balances$(17,096)$(72,586)
Retirement of treasury stock4,867 60,959 
Repurchase of common stock, including excise tax and commission
(27,231)(23,484)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards(9,044)(3,745)
Ending balances$(48,504)$(38,856)
Retained earnings (accumulated deficit)
Beginning balances$(50,934)$(12,788)
Net income
50,237 80,947 
Ending balances$(697)$68,159 
Accumulated other comprehensive loss
Beginning balances$(1,718)$(3,444)
Change in foreign currency translation adjustment(1,116)(863)
Unrealized loss on investments(84)— 
Ending balances$(2,918)$(4,307)
Total stockholders' equity, ending balances$469,127 $594,409 
Common stock shares:
Beginning balances123,046,510130,399,940
Issuance of common stock pursuant to equity incentive plans2,103,9831,268,520
Retirement of treasury stock(421,210)(4,424,500)
Ending balances124,729,283127,243,960
Treasury stock shares:
Beginning balances(1,282,734)(5,286,024)
Retirement of treasury stock421,2104,424,500
Repurchase of common stock(1,884,654)(1,478,597)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards(658,055)(332,550)
Ending balances(3,404,233)(2,672,671)
The accompanying notes are an integral part of these condensed consolidated financial statements.
5

SONOS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in thousands)
Three Months Ended
December 28,
2024
December 30,
2023
Cash flows from operating activities
Net income$50,237 $80,947 
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense25,334 19,358 
Depreciation and amortization17,611 11,878 
Provision for inventory obsolescence1,305 5,837 
Restructuring and abandonment charges 260 
Deferred income taxes123 (45)
Other841 1,236 
Foreign currency transaction (gain) loss2,129 (7,388)
Changes in operating assets and liabilities:
Accounts receivable(41,374)(12,215)
Inventories89,308 167,641 
Other assets(6,437)(12,878)
Accounts payable and accrued expenses(5,940)(7,429)
Accrued compensation12,394 5,988 
Deferred revenue1,513 3,660 
Other liabilities9,129 18,551 
Net cash provided by operating activities156,173 275,401 
Cash flows from investing activities
Purchases of marketable securities(10,128) 
Purchases of property and equipment(13,106)(6,077)
Maturities of marketable securities13,900  
Net cash used in investing activities(9,334)(6,077)
Cash flows from financing activities
Payments for repurchase of common stock, including excise tax and commission(27,165)(23,484)
Payments for repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards(9,044)(3,745)
Proceeds from exercise of common stock options2,411 3,538 
Net cash used in financing activities(33,798)(23,691)
Effect of exchange rate changes on cash and cash equivalents(2,818)1,478 
Net increase in cash and cash equivalents110,223 247,111 
Cash and cash equivalents
Beginning of period169,732 220,231 
End of period$279,955 $467,342 
Supplemental disclosure
Cash paid for interest$63 $58 
Cash paid for taxes, net of refunds$658 $3,684 
Cash paid for amounts included in the measurement of lease liabilities, net of tenant improvement reimbursements received$(2,531)$2,601 
Supplemental disclosure of non-cash investing and financing activities
Purchases of property and equipment in accounts payable and accrued expenses$3,693 $6,141 
Right-of-use assets obtained in exchange for new operating lease liabilities$ $7,637 
Excise tax on share repurchases, accrued but not paid$668 $ 
The accompanying notes are an integral part of these condensed consolidated financial statements.
6

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

1. Business Overview and Basis of Presentation
Description of business
Sonos, Inc. and its wholly owned subsidiaries (collectively, "Sonos," the "Company," "we," "us" or "our") designs, develops, manufactures, and sells audio products and services. The Sonos sound system provides customers with an immersive listening experience created by the design of its speakers, headphones and components, a proprietary software platform, and the ability to stream content from a variety of sources over the customer’s wireless network or over Bluetooth.
The Company’s products are sold through third-party physical retailers, including custom installers of home audio systems, select e-commerce retailers, and its website, sonos.com. The Company’s products are distributed in over 60 countries through its wholly owned subsidiaries: Sonos Europe B.V. in the Netherlands, Beijing Sonos Technology Co. Ltd. in China, Sonos Japan GK in Japan, and Sonos Australia Pty Ltd. in Australia.
Basis of presentation and preparation
The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of September 28, 2024, has been derived from the audited consolidated financial statements of the Company.
The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, (the "Annual Report"), filed with the SEC on November 15, 2024.
In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three months ended December 28, 2024, are not necessarily indicative of the results to be expected for the full fiscal year or any other period.
The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company’s fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company’s fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The three months ended December 28, 2024 and December 30, 2023, spanned 13 weeks each. As used in this Quarterly Report on Form 10-Q, "fiscal 2025" refers to the fiscal year ending September 27, 2025, "fiscal 2024" refers to the fiscal year ended September 28, 2024, and "fiscal 2023" refers to the fiscal year ended September 30, 2023.
Use of estimates and judgments
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.
2. Summary of Significant Accounting Policies
There have been no changes in the Company’s significant accounting policies, recently adopted accounting pronouncements, or recent accounting pronouncements pending adoption from those disclosed in the Annual Report, except as noted below.
7

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
Recent accounting pronouncements pending adoption
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This standard requires disclosure of disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, and amortization. Also required is a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. The amendments may be applied retrospectively or prospectively. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements and related disclosures.
3. Financial Instruments
The carrying values of the Company’s accounts receivable and accounts payable, approximate their fair values due to the short period of time to maturity or repayment. The Company utilizes the following fair value hierarchy to establish priorities of the inputs used to measure fair value:
Level 1: Quoted prices in active markets for identical assets or liabilities.
Level 2: Observable inputs other than quoted market prices included in Level 1, such as quoted prices for similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
The following table summarizes cash, cash equivalents and marketable securities by investment category as of December 28, 2024 and September 28, 2024:
December 28, 2024
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$234,980 $— $— $234,980 $234,980 $— 
Level 1:
Money market funds40,881 — — 40,881 40,881 — 
Subtotal40,881 — — 40,881 40,881 — 
Level 2:
U.S. Treasury securities51,959 50 (13)51,996 4,094 47,902 
Subtotal51,959 50 (13)51,996 4,094 47,902 
Total$327,820 $50 $(13)$327,857 $279,955 $47,902 
8

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)

September 28, 2024
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$144,184 $— $— $144,184 $144,184 $— 
Level 1:
Money market funds25,548 — — 25,548 25,548 — 
Subtotal25,548 — — 25,548 25,548 — 
Level 2:
U.S. Treasury securities51,304 122  51,426  51,426 
Subtotal51,304 122  51,426  51,426 
Total$221,036 $122 $ $221,158 $169,732 $51,426 
Marketable securities
As of December 28, 2024, the Company held no securities with original maturities exceeding one year. Realized gains and losses on the sale of securities are recorded in other income (expense), net in the condensed consolidated statements of operations and comprehensive income.
There were no realized gains or losses on sales of marketable securities during the three months ended December 28, 2024. The Company does not intend to sell the securities, and it is more-likely-than-not that it will not be required to sell before recovery of their amortized cost basis. Accordingly, an allowance for credit losses was deemed unnecessary for these securities as of December 28, 2024.
Accrued interest receivable related to our marketable securities was immaterial as of December 28, 2024. No accrued interest receivables were written off during the three months ended December 28, 2024.
4. Revenue and Geographic Information
Disaggregation of revenue
Revenue is attributed to each region based on ship-to address, and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each region. Revenue by region is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Americas$324,583 $392,439 
Europe, Middle East and Africa ("EMEA")197,612 191,817 
Asia Pacific ("APAC")28,662 28,613 
Total revenue$550,857 $612,869 
Revenue is attributed to individual countries based on ship-to address and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each country. Revenue by significant countries is as follows:
9

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
United States$294,629 $361,850 
Other countries256,228 251,019 
Total revenue$550,857 $612,869 
Revenue by product category also includes the applicable service revenue for software upgrades and cloud-based services attributable to each product category. Revenue by major product category is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Sonos speakers$467,142 $503,011 
Sonos system products60,274 84,562 
Partner products and other revenue23,441 25,296 
Total revenue$550,857 $612,869 
5. Balance Sheet Components
Accounts receivable, net
Accounts receivable, net consist of the following:
December 28,
2024
September 28,
2024
(In thousands)
Accounts receivable$180,272 $96,254 
Allowance for credit losses(2,790)(2,619)
Allowance for sales incentives(92,696)(49,122)
Accounts receivable, net of allowances$84,786 $44,513 
Inventories
Inventories consist of the following:
December 28,
2024
September 28,
2024
(In thousands)  
Finished goods$117,040 $199,825 
Component parts23,852 31,680 
Inventories$140,892 $231,505 
As of December 28, 2024 and September 28, 2024, inventory write-downs were $32.0 million and $33.3 million, respectively.
Property and equipment
Property and equipment net of accumulated depreciation were as follows:
10

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
December 28,
2024
September 28,
2024
(In thousands)
Property and equipment
$284,166 $280,247 
Less: accumulated depreciation
(189,138)(178,099)
Property and equipment, net$95,028 $102,148 
Intangible assets
In the first quarter of fiscal year 2025, the Company determined that the underlying project related to the in-process research and development from the acquisition of Mayht Holding BV ("Mayht") was completed. As a result, the acquired $73.8 million of in-process research and development was reclassified as definite-lived developed technology and will amortize over its estimated economic life of 7 years. The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:
December 28, 2024
Gross Carrying Amount
Accumulated Amortization
Foreign Currency TranslationNet Carrying ValueWeighted-Average Remaining
Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name$451 $(206)$(10)$235 3.25
Technology-based94,419 (10,166) 84,253 6.46
Total intangible assets$94,870 $(10,372)$(10)$84,488 6.45
September 28, 2024
Gross Carrying AmountAccumulated Amortization Foreign Currency Translation Net Carrying ValueWeighted-Average Remaining Life
(In thousands, except weighted-average remaining life)
Trade name
$451 $(188)$7 $270 3.50
Technology-based31,480 (17,484)- 13,996 4.52
Total finite-lived intangible assets31,931 (17,672)7 14,266 4.51
In-process research and development not subject to amortization
73,770 — 73,770 
Total intangible assets$105,701 $(17,672)$7 $88,036 
The following table summarizes the estimated future amortization expense of the Company's intangible assets as of December 28, 2024:
11

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
Fiscal years endingFuture Amortization Expense
(In thousands)
Remainder of fiscal 2025$9,154 
202613,576 
202713,561 
202813,446 
202912,453 
2030 and thereafter22,298 
Total future amortization expense$84,488 
Cloud Computing Arrangements
Capitalized costs to implement cloud computing arrangements net of accumulated amortization are reported as a component of other noncurrent assets on the Company's condensed consolidated balance sheets and were as follows:
December 28,
2024
September 28,
2024
(In thousands)
Cloud computing implementation costs$26,087 $25,038 
Less: accumulated amortization(10,569)(9,697)
Cloud computing implementation costs, net$15,518 $15,341 
Amortization expense for implementation costs for cloud-based computing arrangements for the three months ended December 28, 2024 and December 30, 2023 was $0.9 million.
Accrued expenses
Accrued expenses consisted of the following:
December 28,
2024
September 28,
2024
(In thousands)
Accrued inventory and supply chain costs$48,025 $34,204 
Accrued taxes28,048 19,084 
Accrued advertising and marketing18,905 12,893 
Accrued general and administrative expenses7,911 10,870 
Accrued product development3,045 4,338 
Other accrued payables2,937 6,394 
Total accrued expenses$108,871 $87,783 
Deferred revenue
Amounts invoiced in advance of revenue recognition are recorded as deferred revenue on the condensed consolidated balance sheets. For the three months ended December 28, 2024 and December 30, 2023, deferred revenue included revenue allocated to unspecified software upgrades and cloud-based services of $81.6 million and $85.3 million, respectively, as well as current deferred revenue related to newly launched products sold to resellers not recognized as revenue until the date of general availability was reached.
The following table presents the changes in the Company’s deferred revenue:
12

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Deferred revenue, beginning of period$82,877 $80,838 
Recognition of revenue included in beginning of period deferred revenue(8,221)(4,023)
Revenue deferred, net of revenue recognized on contracts in the respective period7,562 9,090 
Deferred revenue, end of period$82,218 $85,905 
The Company expects the following recognition of deferred revenue as of December 28, 2024:
 For the fiscal years ending
 Remainder of 20252026202720282029 and
Beyond
Total
(In thousands)
Deferred revenue expected to be recognized$16,060 $18,589 $15,974 $12,981 $18,614 $82,218 
Other current liabilities
Other current liabilities consist of the following:
December 28,
2024
September 28,
2024
(In thousands)
Reserve for returns$27,393 $20,304 
Warranty liability10,921 10,565 
Short-term operating lease liabilities7,369 7,551 
Other 6,398 7,857 
Total other current liabilities$52,081 $46,277 
The following table presents the changes in the Company’s warranty liability:
December 28,
2024
December 30,
2023
(In thousands)
Warranty liability, beginning of period$10,565 $7,466 
Provision for warranties issued during the period5,475 5,582 
Settlements of warranty claims during the period(5,119)(4,276)
Warranty liability, end of period$10,921 $8,772 

6. Debt
On October 13, 2021, the Company entered into a Revolving Credit Agreement with JPMorgan Chase Bank, N.A., as the administrative agent, and Bank of America N.A., Morgan Stanley Senior Funding, Inc., and Goldman Sachs Bank USA as the other lenders party thereto (the "Revolving Credit Agreement"). The Revolving Credit Agreement provides for (i) a five-year senior secured revolving credit facility in the amount of up to $100.0 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general
13

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
corporate purposes. In June 2023, the Company amended the Revolving Credit Agreement, replacing prior references to LIBOR with references to SOFR as a result of the discontinuation of LIBOR. The facility may be drawn as an Alternative Base Rate Loan (at 1.00% plus an applicable margin) or Term Benchmark Loan (at the Term SOFR Rate, plus the applicable Term SOFR Adjustment ranging from 0.11% to 0.43%, plus an applicable margin (in total, "Adjusted Term SOFR")). The Company must also pay (i) an unused commitment fee ranging from 0.200% to 0.275% per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over Adjusted Term SOFR multiplied by the aggregate face amount of outstanding letters of credit. As of December 28, 2024, the Company did not have any outstanding borrowings and had $2.4 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement.
The Company’s obligations under the Revolving Credit Agreement are secured by substantially all of the Company’s assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires the Company to maintain a certain consolidated leverage ratio, and customary events of default. As of December 28, 2024, the Company was in compliance with all financial covenants under the Revolving Credit Agreement.
7. Commitments and Contingencies
Commitments to suppliers
As of December 28, 2024, the Company's open purchase orders to contract manufacturers for finished goods were approximately $84 million, the majority of which are expected to be paid over the next six months. As of December 28, 2024, the Company's expected commitments to suppliers for components were in the range of $170 million to $190 million, the majority of which is expected to be paid and/or utilized by our contract manufacturers in building finished goods within the next two years. The expected commitments are subject to change as a result of fluctuations in the demand forecast, as well as ongoing negotiations with contract manufacturers and suppliers. These commitments are related to components that can be specific to Sonos products and comprised 1) indirect obligations to third-party manufacturers and suppliers, 2) the inventory owned by contract manufacturers procured to manufacture Sonos products, and 3) purchase commitments made by contract manufacturers to their upstream suppliers.
Legal proceedings
From time to time, the Company is involved in legal proceedings in the ordinary course of business, including claims relating to employee relations, business practices, and patent infringement. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.
The Company’s Lawsuits Against Google:
On January 7, 2020, the Company filed a complaint with the U.S. International Trade Commission ("ITC") against Alphabet Inc. ("Alphabet") and Google LLC ("Google") and a counterpart lawsuit in the U.S. District Court for the Central District of California against Google. The complaint and lawsuit each allege infringement by Alphabet and Google of certain Sonos patents related to its smart speakers and related technology. The counterpart lawsuit was stayed pending completion of the ITC investigation and appeal thereof. The ITC concluded its investigation in January 2022, finding all five of the Company’s asserted patents to be valid and infringed by Google, and further finding that one redesign per patent proposed by Google would avoid infringement. The ITC issued a limited exclusion order and a cease-and-desist order with respect to Google’s infringing products. The Company and Google each appealed the ITC’s determination, which was upheld in its entirety by a panel of the appeals court. Google's petition for rehearing by the full appeals court has been denied. The stay in the counterpart lawsuit has been lifted. No trial date has been set.
On September 29, 2020, the Company filed another lawsuit against Google alleging infringement of additional Sonos patents and seeking monetary damages and other non-monetary relief. A jury trial was held in May 2023, which found one Sonos patent to be infringed and another Sonos patent not infringed, and returned an award of $32.5 million
14

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
based on a royalty rate of $2.30 per infringing unit. After trial, the court held Sonos’ patents unenforceable under the doctrine of prosecution laches and invalid as a result of amendments made during prosecution. The Company is appealing the ruling.
Google’s Lawsuits Against the Company:
On June 11, 2020, Google filed a lawsuit in the U.S. District Court for the Northern District of California against the Company alleging infringement by the Company of five Google patents and seeking monetary damages and other non-monetary relief. All five of these patents have since been found invalid or non-infringed by the Court or by the U.S. Patent and Trademark Office or have been withdrawn from the case by Google. The Court has now entered final judgment for Sonos and against Google. Google has appealed.
On August 8, 2022, Google filed two complaints with the ITC against the Company and two counterpart lawsuits in the Northern District of California against the Company, collectively alleging infringement by the Company of seven Google patents generally related to wireless charging, device setup, and voice control, and seeking monetary damages and other non-monetary relief. The counterpart lawsuits are stayed pending completion of the ITC investigations. The ITC has terminated the investigation as to one Google patent as a result of imminent expiration of that Google patent. The first ITC investigation concluded in December 2023 with a final determination of no violation by the Company. Google chose not to appeal this determination. The oral hearing in the second ITC investigation has been postponed after the administrative law judge has indicated that she will be invalidating both Google patents at issue.
Implicit
On March 10, 2017, Implicit, LLC (“Implicit”) filed a patent infringement action in the United States District Court, District of Delaware against the Company. Implicit is asserting that the Company has infringed on certain claims of two patents in this case. The Company denies the allegations. The claims at issue have been held unpatentable by the U.S. Patent and Trademark Office. Implicit has appealed this ruling, which is currently scheduled to be heard by the appeals court by mid-2025. A range of loss, if any, associated with this matter is not probable or reasonably estimable as of December 28, 2024.
The Company is involved in certain other litigation matters not listed above but does not consider these matters to be material either individually or in the aggregate at this time. The Company’s view of the matters not listed may change in the future as the litigation and events related thereto unfold.
8. Stockholders' Equity
On November 15, 2023, the Board of Directors (the "Board") authorized a common stock repurchase program of up to $200.0 million. During the three months ended December 28, 2024, the Company repurchased 1,884,654 shares for an aggregate purchase price of $27.1 million and at an average price of $14.40 per share under the repurchase program. Aggregate purchase price and average price per share exclude commission and excise tax. As of January 1, 2023, the Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the condensed consolidated statements of equity. The Company had $43.9 million available for share repurchases under the repurchase program as of December 28, 2024.
Treasury stock during the three months ended December 28, 2024, included 658,055 shares withheld to satisfy employees' tax withholding requirements in connection with vesting of stock awards. Additionally, during the three months ended December 28, 2024, the Company retired 421,210 shares of treasury stock.
9. Stock-based Compensation
2018 Equity Incentive Plan
In July 2018, the Board adopted the 2018 Equity Incentive Plan (the "2018 Plan").
Stock options
The summary of the Company’s stock option activity is as follows:
15

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
Number of Options Weighted-Average Exercise PriceWeighted-Average Remaining
Contractual Term
Aggregate Intrinsic Value
(In years)(In thousands)
Outstanding at September 28, 20247,082,389$14.24 2.8$210 
Exercised(177,433)$13.60  
Forfeited / expired(137,698)$14.73  
Outstanding at December 28, 20246,767,258$14.24 2.6$5,852 
As of December 28, 2024 and September 28, 2024, all outstanding stock options have vested and the Company had no unrecognized stock-based compensation expense related to stock options.
Restricted stock units ("RSU")
Pursuant to the 2018 Plan, the Company issues RSUs to employees and directors. The summary of the Company’s RSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value
Aggregate Intrinsic Value
(In thousands)
Outstanding at September 28, 202410,763,098$14.79 $130,772 
Granted6,737,566$12.38  
Released(1,919,356)$13.79  
Forfeited(492,848)$14.04  
Outstanding at December 28, 202415,088,460$13.87 $226,629 
As of December 28, 2024 and September 28, 2024, the Company had $156.8 million and $115.4 million of unrecognized stock-based compensation expense related to RSUs, which are expected to be recognized over weighted-average periods of 2.6 and 2.4 years, respectively.
Performance stock units ("PSU")
Pursuant to the 2018 Plan, the Company has issued and may issue certain PSUs that vest on the satisfaction of service and performance conditions. The number of outstanding PSUs is based on the target number of share awards. The number of shares vested at the end of the performance period is based on achievement of performance conditions and may include adjustments to reflect the extent to which the corresponding performance goals have been achieved. The summary of the Company’s PSU activity is as follows:
16

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
Number of Units
Weighted-Average Grant Date Fair
Value
Aggregate Intrinsic Value
(In thousands)
Outstanding at September 28, 2024684,080$18.37 $8,312 
Released(7,194)$17.54 
Performance adjustment(1)
(121,250)$21.80 
Outstanding at December 28, 2024555,636$17.63 $8,346 
(1) Represents adjustment based on actual achievement of performance-based awards.
As of December 28, 2024 and September 28, 2024, the Company had $0.1 million and $0.2 million of unrecognized stock-based compensation expense related to PSUs, which are expected to be recognized over weighted-average period of 1.5 years.
Stock-based compensation
Total stock-based compensation expense by functional category was as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Cost of revenue$1,349 $654 
Research and development13,315 8,979 
Sales and marketing5,632 3,815 
General and administrative5,038 5,910 
Total stock-based compensation expense$25,334 $19,358 
10. Income Taxes
The Company’s income tax provision and the resulting effective tax rate for interim periods is generally determined based upon its estimated annual effective tax rate ("AETR"), adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a higher or lower effective tax rate during a quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the AETR, and if the estimated AETR changes, a cumulative adjustment is made in that quarter.
The Company recorded a benefit from income taxes of $6.4 million and a provision for income taxes of $12.0 million for the three months ended December 28, 2024 and December 30, 2023, respectively, related to U.S. and non-U.S. income taxes. The negative U.S. AETR is driven by anticipated income tax expense on a forecasted U.S. book loss resulting from capitalizing research and development expense pursuant to U.S. Internal Revenue Code ("Section 174") with no corresponding deferred tax benefit.
For the three months ended December 28, 2024, the Company utilized the AETR method to calculate separate U.S. and foreign income tax provisions. Separate U.S. and foreign AETRs were calculated in accordance with US GAAP since Sonos Inc is forecasted in a full-year loss with no corresponding deferred tax benefit while all non-U.S. entities are forecasted to profitability and, unlike the prior year, small fluctuations in forecasted pre-tax income (loss) are not expected to have a material impact on the estimated U.S. AETR. For the three months ended December 30, 2023, the Company calculated its U.S. income tax provision using the discrete method as though the interim period was an annual period since minor deviations in the projected pre-tax net income (loss) in the U.S. could have resulted in a disproportionate and unreliable effective tax rate under the AETR method.
17

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
For the three months ended December 28, 2024, the Company’s tax benefit resulted from the application of a negative U.S. AETR to year-to-date U.S. pretax income offset in part by a tax provision for non-U.S. income taxes. For the three months ended December 30, 2023, the Company's U.S. income tax provision was adversely impacted by Section 174 as the Company recorded a current U.S. tax expense with no corresponding deferred tax benefit due to the valuation allowance maintained against its U.S. deferred tax assets.
For the three months ended December 28, 2024, the Company concluded that a full valuation allowance on its deferred tax assets in the U.S. continued to be appropriate considering cumulative pre-tax losses in recent years and uncertainty with respect to future taxable income. Release of the valuation allowance in the U.S. would result in a benefit to the income tax provision in the period the release is recorded, which could have a material impact on net earnings. The timing and amount of the potential valuation allowance release are subject to significant management judgment, as well as prospective earnings in the U.S.
11. Net Income Per Share
Basic net income per share attributable to common stockholders is calculated by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding less shares subject to repurchase. Diluted net income per share attributable to common stockholders adjusts the basic net income per share attributable to common stockholders and the weighted-average number of shares of common stock outstanding for the potentially dilutive impact of stock awards, using the treasury stock method.
The following table sets forth the computation of the Company’s basic and diluted net income per share attributable to common stockholders:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands, except share and per share data)
Numerator:
Net income attributable to common stockholders - basic and diluted
$50,237 $80,947 
Denominator:
Weighted-average shares of common stock—basic122,071,586125,181,717
Effect of potentially dilutive stock options34,490 133,009 
Effect of RSUs2,616,466 1,424,312 
Effect of PSUs9,077 3,115 
Weighted-average shares of common stock—diluted124,731,619126,742,153
Net income per share attributable to common stockholders:
Basic$0.41 $0.65 
Diluted$0.40 $0.64 
The following potentially dilutive shares were excluded from the computation of diluted net income per share attributable to common stockholders because including them would have been antidilutive:
Three Months Ended
December 28,
2024
December 30,
2023
Stock options to purchase common stock6,934,5538,300,168
Restricted stock units13,147,9229,903,792
Performance stock units7,51029,436
Total20,089,98518,233,396
18

SONOS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(unaudited)
12. Retirement Plans
The Company has a defined contribution 401(k) plan (the "401(k) Plan") for the Company’s U.S.-based employees, as well as various defined contribution plans for its international employees. Eligible U.S. employees may make tax-deferred contributions under the 401(k) plan but are limited to the maximum annual dollar amount allowable under the Internal Revenue Code of 1986, as amended (the "Code"). The Company matches contributions towards the 401(k) Plan and international defined contribution plans. The Company's matching contributions totaled $2.3 million and $2.6 million for the three months ended December 28, 2024 and December 30, 2023, respectively.
13. Subsequent Events
On January 13, 2025, the Company announced that Patrick Spence would be stepping down as Chief Executive Officer (“CEO”) and as a member of the Board, effective immediately. In connection with Mr. Spence’s departure, the Board appointed Tom Conrad as Interim CEO and President, effective January 13, 2025. Mr. Conrad will remain a member of the Board; however he has resigned from his position as Chair and member of the Compensation, People and Diversity & Inclusion Committee of the Board in connection with his appointment as Interim CEO.
On January 13, 2025, the Company informed Maxime Bouvat-Merlin, the Company’s Chief Product Officer (“CPO”), that the Company had eliminated the CPO role, effective immediately. The Company and Mr. Bouvat-Merlin have agreed that he will remain employed by the Company as an advisor to the Interim CEO for a mutually agreed transition period.
On February 5, 2025, the Company announced a reorganization and reduction in force involving approximately 12% of its employees to improve the Company's operating model and cost structure and set the Company up for long-term success. The Company estimates that it will incur approximately $15 million to $18 million of restructuring and related charges, substantially all of which are related to employee severance and benefits costs. The Company expects to incur substantially all of the restructuring and related charges in the second quarter of fiscal 2025.
19

Item 2. Management's discussion and analysis of financial condition and results of operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited consolidated financial statements included in our Annual Report.
We operate on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. Our fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters.
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding future operations and performance, are forward-looking statements. In some cases, forward-looking statements may be identified by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "could," "would," "expect," "objective," "plan," "potential," "seek," "grow," "target," "if," and similar expressions intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations, objectives, restructuring efforts, timing of certain tax impacts and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in the section titled "Risk Factors" set forth in Part I, Item 1A of the Annual Report and in our other SEC filings. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results may differ materially and adversely from those anticipated or implied in the forward-looking statements. You should read this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Overview
Sonos is one of the world's leading sound experience brands.
We pioneered multi-room, wireless audio products, debuting the world’s first multi-room wireless sound system in 2005. In October 2024, we introduced Arc Ultra, our new premium soundbar debuting Sound Motion TM, our revolutionary transducer technology, and Sonos Sub 4, the next generation of our iconic subwoofer with a refreshed design and internals. Today, our product lineup includes wireless, portable, and home theater speakers, headphones, components, and accessories to address consumers’ evolving audio needs. We are known for delivering unparalleled sound, thoughtful design aesthetic, simplicity of use, and an open platform. Our platform has attracted a broad range of more than 100 streaming content providers, such as Apple Music, Spotify, Deezer, and Pandora. These partners find value in our independent platform and access to our millions of desirable and engaged customers. We frequently introduce new services and features across our platform, providing our customers with enhanced functionality, improved sound, and an enriched user experience. In May 2024, we launched an extensive redesign of our Sonos app. We rebuilt the app from the ground up with the purpose of improving the user experience through a modern user interface and to provide a modular developer platform allowing us to drive more innovation faster in the future. We are committed to continuous technological innovation as reflected in our growing global patent portfolio. We believe our patents comprise the foundational intellectual property for wireless multi-room and other audio technologies.
We generate revenue from the sale of our Sonos speaker products, including wireless speakers, home theater speakers and beginning in June 2024, headphones, from our Sonos system products, including our component products, and from partner products and other revenue, including Sonos and third-party accessories and partnerships.
Key Metrics
In addition to the measures presented in our condensed consolidated financial statements, we use the following key metrics to evaluate our business, measure our performance, identify trends affecting our business and assist us in
20

making operational and strategic decisions. Our key metrics are total revenue, products sold, Adjusted EBITDA, and Adjusted EBITDA margin. The most directly comparable financial measure calculated under U.S. GAAP for Adjusted EBITDA is net income. The most directly comparable financial measure calculated under U.S. GAAP for Adjusted EBITDA margin is net income margin.
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands, except percentages)
Total revenue$550,857 $612,869 
Products sold1,850 2,109 
Net income
$50,237 $80,947 
Net income margin(1)
9.1 %13.2 %
Adjusted EBITDA(2)
$91,173 $115,242 
Adjusted EBITDA margin(2)
16.6 %18.8 %
(1)Net income margin is calculated by dividing net income by revenue.
(2)For additional information regarding Adjusted EBITDA and Adjusted EBITDA margin (which are non-GAAP financial measures), including reconciliations of net income to Adjusted EBITDA, see the section titled "Non-GAAP Financial Measures" below.
Products Sold
Products sold represents the number of products that are sold during a period, net of returns and includes the sale of products in the Sonos speakers and Sonos system products categories, as well as module units sold through our partnerships with IKEA and Sonance from our Partner products and other revenue category. Growth rates between products sold and revenue are not perfectly correlated because our revenue is affected by other variables, such as the mix of products sold during the period, promotional discount activity, the introduction of new products that may have higher or lower than average selling prices, changes to selling prices, as well as the impact of recognition of previously deferred revenue.
Non-GAAP Financial Measures
To supplement our condensed consolidated financial statements presented in accordance with U.S. GAAP, we use Adjusted EBITDA, Adjusted EBITDA margin, and constant currency which are non-GAAP financial measures. We use these non-GAAP financial measures to evaluate our operating performance and trends and make planning decisions. We believe that these non-GAAP financial measures help identify underlying trends in our business that could otherwise be masked by the effect of the expenses and other items that we exclude from these non-GAAP financial measures. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects, and allowing for greater transparency with respect to a key financial metric used by our management in its financial and operational decision-making.
We define Adjusted EBITDA as net income adjusted to exclude the impact of depreciation and amortization, stock-based compensation expense, interest income, interest expense, other income (expense), income taxes, legal and transaction related costs, restructuring and abandonment costs, and other items that we do not consider representative of underlying operating performance. We define Adjusted EBITDA margin as Adjusted EBITDA divided by revenue.
We present percentage sales growth in constant currency to show performance unaffected by fluctuations in currency exchange rates. We calculate constant currency growth percentages by translating our current period financial results using the prior period average currency exchange rates and comparing these amounts to our prior period reported results.
These non-GAAP financial measures are not based on standardized methodology prescribed by U.S. GAAP and are not necessarily comparable to similarly titled measures presented by other companies. Furthermore, other companies may not publish these or similar metrics. These metrics may also have certain limitations as they do not include the impact of certain expenses that are reflected in our condensed consolidated statements of operations and comprehensive income,
21

including stock-based compensation, which has been and will continue to be, a significant recurring expense for our business and an important part of our compensation strategy. Because of these limitations, these non-GAAP financial measures should be considered along with other operating and financial performance measures presented in accordance with U.S. GAAP.
The following table presents a reconciliation of net income to Adjusted EBITDA:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands, except percentages)
Net income $50,237 $80,947 
Add (deduct):
Depreciation and amortization17,611 11,878 
Stock-based compensation expense25,334 19,358 
Interest income(1,861)(3,075)
Interest expense110 105 
Other (income) expense, net6,029 (10,274)
Provision for (benefit from) income taxes(6,422)11,992 
Legal and transaction related costs(1)
195 3,743 
Restructuring and abandonment costs(2)
(60)568 
Adjusted EBITDA$91,173 $115,242 
Revenue$550,857 $612,869 
Net income margin9.1 %13.2 %
Adjusted EBITDA margin16.6 %18.8 %
(1)Legal and transaction-related costs consist of expenses related to our intellectual property ("IP") litigation against Alphabet and Google, as well as legal and transaction costs associated with our acquisition activity, which we do not consider representative of our underlying operating performance.
(2)On August 14, 2024, we initiated a restructuring plan to reduce our cost base involving approximately 6% of our employees (the "2024 restructuring plan"). Substantially all restructuring related costs were incurred in the fourth quarter of fiscal 2024. In the first quarter of fiscal 2025, we recorded a gain resulting from the impact of remaining restructuring costs that were lower than our estimated liability. The gain was recognized as a credit in research and development expenses on the condensed consolidated statements of operations and comprehensive income. For fiscal 2024, restructuring and abandonment costs also include nominal remaining costs incurred related to the restructuring plan incurred on June 14, 2023.
22

Results of Operations
Comparison of the three months ended December 28, 2024 and December 30, 2023
Revenue
Comparison of the three months ended December 28, 2024 and December 30, 2023
Three Months EndedChange
December 28,
2024
December 30,
2023
$%
(In thousands, except percentages)$%$%
Sonos speakers$467,142 84.8 %$503,011 82.1 %$(35,869)(7.1)%
Sonos system products60,274 10.9 84,562 13.8 (24,288)(28.7)
Partner products and other revenue23,441 4.3 25,296 4.1 (1,855)(7.3)
Total revenue$550,857 100.0 %$612,869 100.0 %$(62,012)(10.1)%
Volume data (products sold/units in thousands)Units%
Total products sold1,8502,109(259)(12.3)%
We generate substantially all of our revenue from the sale of Sonos speakers and Sonos system products. We also generate a portion of revenue from Partner products and other revenue sources, including accessories such as speaker stands and wall mounts, and architectural speakers from our Sonance partnership.
Total revenue decreased $62.0 million, or 10.1%, for the three months ended December 28, 2024 compared to the three months ended December 30, 2023, driven by softer demand due to market conditions and challenges resulting from our 2024 app rollout, partially offset by the introduction of Arc Ultra in October 2024 and Ace in June 2024.
Sonos speakers revenue represented 84.8% of total revenue for the three months ended December 28, 2024 and decreased 7.1% compared to the three months ended December 30, 2023, primarily driven by expected declines in Arc and Sonos One, as well as Move, partially offset by the introduction of Arc Ultra and Ace, as well as Era 100. Sonos system products represented 10.9% of total revenue for the three months ended December 28, 2024 and decreased 28.7% compared to the three months ended December 30, 2023, due to lower sales to our installed solutions channel. Partner products and other revenue represented 4.3% of total revenue for the three months ended December 28, 2024 and decreased 7.3% compared to the three months ended December 30, 2023.
The volume of products sold decreased 12.3% for the three months ended December 28, 2024 compared to the three months ended December 30, 2023, primarily driven by expected declines in Arc and Sonos One, as well as Move, and partially offset by the introduction of Arc Ultra and Ace, as well as Era 100.
Revenue by Region
Three Months Ended
Change
December 28,
2024
December 30,
2023
$
%
Constant
Currency
Change (1)
(In thousands, except percentages)
Americas$324,583 $392,439 $(67,856)(17.3)%(16.9)%
EMEA197,612 191,817 5,795 3.0 2.1 
APAC28,662 28,613 49 0.2 (1.5)
Total revenue$550,857 $612,869 $(62,012)(10.1)%(10.2)%
(1)Constant currency is a financial measure that is not calculated in accordance with U.S. GAAP. For additional information, see the section titled "Non-GAAP Financial Measures" above.
23

Cost of Revenue and Gross Profit
Comparison of the three months ended December 28, 2024 and December 30, 2023
Three Months EndedChange
December 28,
2024
December 30,
2023
$ %
(In thousands, except percentages)
Cost of revenue$309,451 $330,190 $(20,739)(6.3)%
Gross profit$241,406 $282,679 $(41,273)(14.6)%
Gross margin43.8 %46.1 %
Cost of revenue consists of product costs, including costs of our contract manufacturers for production, components, shipping and handling, tariffs, duty costs, warranty replacement costs, packaging, fulfillment costs, manufacturing and tooling equipment depreciation, warehousing costs, hosting costs, and excess and obsolete inventory write-downs. It also includes licensing costs, such as royalties to third parties, and attributable amortization of acquired developed technology. In addition, we allocate certain costs related to management and facilities, personnel-related expenses, and supply chain logistic costs. Personnel-related expenses consist of salaries, bonuses, benefits, and stock-based compensation expenses.
Our gross margin has fluctuated and may, in the future, fluctuate from period to period based on a number of factors, including the mix of products we sell, the mix of channels through which we sell our products, fluctuations of our product and material cost saving initiatives, fluctuations in our product and material markets, promotional activity, the foreign currency in which our products are sold, and tariffs and duty costs implemented by governmental authorities.
Cost of revenue decreased $20.7 million, or 6.3%, for the three months ended December 28, 2024 compared to the three months ended December 30, 2023, primarily due to a decrease in products sold as well as a decrease in product and material costs, partially offset by a shift into higher cost products.
Gross margin decreased 230 basis points for the three months ended December 28, 2024 compared to the three months ended December 30, 2023, primarily due to an increase in inventory-related write-downs, unfavorable channel mix, and increased depreciation and amortization primarily related to the reclassification of our Mayht in-process research and development into finite-lived intangible assets, partially offset by decreased product and material costs.
24

Operating Expenses
Comparison of the three months ended December 28, 2024 and December 30, 2023
Three Months Ended
Change from Prior Fiscal Year
December 28, 2024December 30, 2023$
%
(Dollars in thousands)
Research and development$80,898 $78,912 $1,986 2.5 %
Restructuring and abandonment costs(1)
(60)323 (383)(118.6)
Total research and development$80,838 $79,235 $1,603 2.0 %
Percentage of revenue14.7 %12.9 %
Sales and marketing$86,644 $83,837 $2,807 3.3 %
Restructuring and abandonment costs(1)
— 113 (113)(100.0)
Total sales and marketing$86,644 $83,950 $2,694 3.2 %
Percentage of revenue15.7 %13.7 %
General and administrative$25,831 $39,667 $(13,836)(34.9)%
Restructuring and abandonment costs(1)
— 132 (132)(100.0)
Total general and administrative$25,831 $39,799 $(13,968)(35.1)%
Percentage of revenue4.7 %6.5 %
Operating expenses$193,373 $202,416 $(9,043)(4.5)%
Restructuring and abandonment costs(1)
(60)568 (628)(110.6)
Total operating expenses$193,313 $202,984 $(9,671)(4.8)%
Percent of revenue35.1 %33.1 %
(1)    On August 14, 2024, we initiated the 2024 restructuring plan. Substantially all restructuring related costs were incurred in the fourth quarter of fiscal 2024. In the first quarter of fiscal 2025, we recorded a gain resulting from the impact of remaining restructuring costs that were lower than our estimated liability. The gain was recognized as a credit in research and development expenses on the condensed consolidated statements of operations and comprehensive income. For fiscal 2024, restructuring and abandonment costs also include nominal remaining costs incurred related to the restructuring plan incurred on June 14, 2023.
Research and Development
Research and development expenses consist primarily of personnel-related expenses, consulting and contractor expenses, tooling, test equipment, prototype materials, and related overhead costs. To date, software development costs have been expensed as incurred because the period between achieving technological feasibility and the release of the software has been short and development costs qualifying for capitalization have been insignificant.
Research and development expenses increased $1.6 million, or 2.0%, for the three months ended December 28, 2024 compared to the three months ended December 30, 2023. This increase was primarily driven by a stock-based compensation expense related to retention of key personnel, partially offset by lower personnel-related costs due to lower headcount.
Sales and Marketing
Sales and marketing expenses consist primarily of advertising and marketing activity for our products and personnel-related expenses, as well as trade show and event costs, sponsorship costs, consulting and contractor expenses, travel costs, depreciation for product displays, as well as related maintenance and repair expenses, customer experience and technology support tool expenses, revenue related sales fees from our direct-to-consumer business, and related overhead costs.
Sales and marketing expenses increased $2.7 million, or 3.2%, for the three months ended December 28, 2024 compared to the three months ended December 30, 2023. This was primarily driven by app recovery spend and
25

depreciation costs associated with a refresh of our product displays deployed at retail locations, partially offset by lower revenue-related sales fees.
General and Administrative
General and administrative expenses consist of administrative personnel-related expenses for our finance, legal, human resources and similar personnel, as well as the costs of professional services, information technology, litigation, patents, related overhead, and other administrative expenses.
General and administrative expenses decreased $14.0 million, or 35.1%, for the three months ended December 28, 2024 compared to the three months ended December 30, 2023. This decrease was primarily driven by lower personnel and facilities costs following the 2024 restructuring plan and a decrease in legal fees mainly related to our IP litigation.
Interest Income, Interest Expense, and Other Income (Expense), Net
Comparison of the three months ended December 28, 2024 and December 30, 2023
Three Months Ended
Change
December 28,
2024
December 30,
2023
$
%
(In thousands, except percentages)
Interest income$1,861 $3,075 $(1,214)(39.5 %)
Interest expense(110)(105)(5)4.8 
Other income (expense), net
(6,029)10,274 (16,303)(158.7)
Total other income, net$(4,278)$13,244 $(17,522)(132.3)%
Interest income consists primarily of interest income earned on our cash, cash equivalents, and marketable securities balances. Interest expense consists primarily of interest expense associated with our debt financing arrangements and amortization of debt issuance costs. Other income, net consists primarily of our foreign currency exchange gains and losses relating to transactions and remeasurement of asset and liability balances denominated in currencies other than the U.S. dollar. We expect our foreign currency gains and losses to continue to fluctuate in the future due to changes in foreign currency exchange rates.
Interest income for the three months ended December 28, 2024 compared to the three months ended December 30, 2023, decreased due to lower cash balances. Interest expense for the three months ended December 28, 2024 compared to the three months ended December 30, 2023, increased primarily due to increased expenses associated with our Revolving Credit Agreement and banking partners. Other income (expense), net for the three months ended December 28, 2024 compared to the three months ended December 30, 2023, decreased from other income of $10.3 million for the three months ended December 30, 2023 to other expense of $6.0 million for the three months ended December 28, 2024 due to foreign currency exchange fluctuations.
Provision for (Benefit from) Income Taxes
Comparison of the three months ended December 28, 2024 and December 30, 2023
Three Months EndedChange
December 28,
2024
December 30,
2023
$
%
(In thousands, except percentages)
Provision for (benefit from) income taxes
$(6,422)$11,992 $(18,414)(153.6)%
We recognized a tax benefit of $6.4 million for the three months ended December 28, 2024, compared to a provision for income taxes of $12.0 million for the three months ended December 30, 2023. This decrease was driven by a change in the prescribed US GAAP method to calculate the interim income tax benefit for the period ending December 28, 2024 versus the method used to calculate the income tax provision for the period ending December 30, 2023.
26

For the three months ended December 28, 2024, we utilized the AETR method to calculate separate U.S. and foreign income tax provisions. Separate U.S. and non-U.S. AETRs were calculated in accordance with interim US GAAP reporting requirements since, unlike the prior year, small fluctuations in forecasted pre-tax income (loss) are not expected to have a material impact on the estimated U.S. AETR. For the three months ended December 30, 2023, we calculated our U.S. income tax provision using the discrete method as though the interim period was an annual period, since minor deviations in the projected pre-tax loss in the U.S. could have resulted in a disproportionate and unreliable effective tax rate under the AETR method.
Liquidity and Capital Resources
Our operations are financed primarily through cash flows from operating activities. As of December 28, 2024, our principal sources of liquidity consisted of cash flows from operating activities, cash and cash equivalents of $280.0 million, including $143.3 million held by our foreign subsidiaries, marketable securities of $47.9 million, proceeds from the exercise of stock options, and borrowing capacity under the credit facility under our Revolving Credit Agreement. In accordance with our policy, the undistributed earnings of our non-U.S. subsidiaries remain indefinitely reinvested outside of the United States as of December 28, 2024, as they are required to fund needs outside of the United States. In the event funds from foreign operations are needed to fund operations in the United States and if U.S. tax has not already been previously provided, we may be required to accrue and pay additional U.S. taxes to repatriate these funds.
We believe our existing cash and cash equivalent balances, cash flows from operations and committed credit lines will be sufficient to meet our long-term working capital and capital expenditure needs for at least the next 12 months. We hold our cash with a diverse group of major financial institutions and have processes and safeguards in place to manage our cash balances and mitigate the risk of loss. In October 2021, we entered into the Revolving Credit Agreement, which allows us to borrow up to $100 million, with a maturity date of October 2026. Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our rate of revenue growth, the timing and extent of spending on research and development efforts and other business initiatives, our planned sales and marketing activities, the timing of new product introductions, our potential merger and acquisition activity, market acceptance of our products, and overall economic conditions. To the extent that current and anticipated sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in increased dilution to our stockholders. If we were to incur additional debt financing, it would result in increased debt service obligations and the instruments governing such debt could require additional operating and financing covenants that would restrict our operations.
Debt Obligations
On October 13, 2021, we entered into the Revolving Credit Agreement. The Revolving Credit Agreement provides for (i) a five year senior secured revolving credit facility in the amount of up to $100 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general corporate purposes. The facility may be drawn as an Alternative Base Rate Loan (at 1.00% plus an applicable margin) or Term Benchmark Loan (SOFR plus an applicable margin). We must also pay (i) an unused commitment fee ranging from 0.200% to 0.275% per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over SOFR multiplied by the aggregate face amount of outstanding letters of credit. As of December 28, 2024, we did not have any outstanding borrowings and had $2.4 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement.
Our obligations under the Revolving Credit Agreement are secured by substantially all of our assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires us to maintain a certain consolidated leverage ratio, and customary events of default. As of December 28, 2024, we were in compliance with all financial covenants under the Revolving Credit Agreement.
27

Cash Flows
The following table summarizes our cash flows for the periods indicated:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Net cash provided by (used in):
Operating activities$156,173 $275,401 
Investing activities(9,334)(6,077)
Financing activities(33,798)(23,691)
Effect of exchange rate changes(2,818)1,478 
Net increase in cash and cash equivalents
$110,223 $247,111 
Cash flows from operating activities
Net cash provided by operating activities of $156.2 million for the three months ended December 28, 2024, consisted of net income of $50.2 million, non-cash adjustments of $47.3 million, and a favorable impact of net changes in operating assets and liabilities of $58.6 million. Non-cash adjustments primarily consisted of stock-based compensation expense and depreciation and amortization. The net increase in cash from the change in operating assets and liabilities was primarily due to a decrease in inventories of $89.3 million as the result of measures taken to more efficiently manage inventory, an increase in accrued compensation of $12.4 million, and an increase in other liabilities of $9.1 million primarily for provisions for our returns. The net increase in cash from the change in operating assets and liabilities was partially offset by an increase in accounts receivable of $41.4 million.
Cash flows from investing activities
Cash used in investing activities of $9.3 million for the three months ended December 28, 2024, primarily consisted of the purchases of marketable securities of $10.1 million and purchases of property and equipment of $13.1 million mainly related to point-of-sale product displays and manufacturing-related tooling and test equipment to support the launch of new products, partially offset by cash provided by maturities of marketable securities of $13.9 million.
Cash flows from financing activities
Cash used in financing activities of $33.8 million for the three months ended December 28, 2024, primarily consisted of payments for repurchases of common stock of $27.2 million and payments for repurchases of common stock related to shares withheld for tax in connection with vesting of stock awards of $9.0 million, partially offset by proceeds from the exercise of stock options of $2.4 million.
Commitments and Contingencies
See Note 7. Commitments and Contingencies in the notes to condensed consolidated financial statements.
Critical Accounting Policies and Estimates
Our unaudited condensed consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates.
Other than items discussed in Note 2 of our condensed consolidated financial statements, there have been no material changes to our critical accounting policies as compared to the critical accounting policies and significant judgments and estimates disclosed in our Annual Report on Form 10-K.
28

Item 3.     Quantitative and Qualitative Disclosures About Market Risk
We are exposed to financial market risks, including changes in currency exchange rates and interest rates. For quantitative and qualitative disclosures about market risk, refer to Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in our Annual Report on Form 10-K. Our exposure to market risk has not changed materially, except as follows:
Foreign Currency Risk
Our inventory purchases are primarily denominated in U.S. dollars. Our international sales are primarily denominated in foreign currencies and any movement in the exchange rate between the U.S. dollar and the currencies in which we conduct sales in foreign countries could have an impact on our revenue, principally for sales denominated in the euro and the British pound. A portion of our operating expenses are incurred outside the United States and are denominated in foreign currencies, which are also subject to foreign currency exchange rate fluctuations. In certain countries where we may invoice customers in the local currency our revenues benefit from a weaker dollar and are adversely affected by a stronger dollar. The opposite impact occurs in countries where we record expenses in local currencies. In those cases, our costs and expenses benefit from a stronger dollar and are adversely affected by a weaker dollar.
We have not entered into any material foreign exchange contracts or derivatives to hedge any foreign currency exposures. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. Our continued international expansion increases our exposure to exchange rate fluctuations and, as a result, such fluctuations could have a significant impact on our future results of operations.
For the three months ended December 28, 2024 and December 30, 2023, we recognized a loss from foreign currency exchange of $6.0 million and gain of $10.1 million, respectively. Based on transactions denominated in currencies other than U.S. dollar as of December 28, 2024, a hypothetical adverse change of 10% would have resulted in an adverse impact on income before benefit from income taxes of approximately $9.3 million for the three months ended December 28, 2024.
Item 4.     Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including the Interim Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required under Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended ("Exchange Act") as of December 28, 2024. Based on that evaluation, the Interim Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.
Changes in Internal Control
There were no changes in our internal control over financial reporting in management's evaluation pursuant to Rule 13a-15(f) during the quarter ended December 28, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
29

PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. Other than the matters described in Note 7. Commitments and Contingencies of the notes to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q, we were not a party to any legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.
Item 1A. Risk Factors
Our operations and financial results are subject to various risks and uncertainties, including the factors discussed in Part I, Item 1A, Risk Factors in our Annual Report on Form 10-K for the year ended September 28, 2024, which could adversely affect our business, reputation, financial condition and operating results, and affect the trading price of our common stock. There have been no material changes to the risk factors disclosed in our Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Recent Sales of Unregistered Securities
None.
Issuer Purchases of Equity Securities
The following table presents information with respect to the Company's repurchase of common stock during the quarter ended December 28, 2024.
Period
Total Number of Shares
Purchased (1)
Average Price Paid per ShareTotal Number of Shares Purchased
as Part of Publicly Announced
Plans or Programs
Approximate Dollar Value of
Shares that May Yet Be
Purchased Under the Plans or
Programs
(in thousands)(2)
Sep 29- Oct 26$— $71,069 
Oct 27 - Nov 23$— $71,069 
Nov 24 - Dec 281,884,654$14.40 1,884,654$43,928 
Total1,884,6541,884,654
(1)In November 2023, the Board authorized a common stock repurchase program of up to $200 million. During the three months ended December 28, 2024, the Company repurchased 1,884,654 shares for an aggregate purchase price of $27.1 million, and an average price of $14.40 per share under the repurchase program. Aggregate purchase price and average price per share exclude commission and excise tax. See Note 8. Stockholders' Equity of the Company's condensed consolidated financial statements for further information. The Company withholds shares of common stock from certain employees in connection with the vesting of stock awards issued to such employees to satisfy applicable tax withholding requirements. Although these withheld shares are not issued or considered common stock repurchases under the Company's stock repurchase program and therefore are not included in the preceding table, they are treated as common stock repurchases in the Company's financial statements as they reduce the number of shares that would have been issued upon vesting.
(2)Approximate dollar value of shares that may yet to be purchased under the plans or programs does not include the impact of direct costs incurred to acquire shares.
30

Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
Rule 10b5-1 Trading Plans and Non-Rule 10b5-1 Trading Arrangements
On November 15, 2024, Joanna Coles, a member of the Company's Board of Directors, terminated her trading plan intended to satisfy the requirements of Rule 10b5-1(c), originally adopted on December 7, 2023 for the sale of up to 10,860 shares of the Company's common stock. The plan was originally scheduled to terminate on the earlier of the date all shares under the plan were sold or April 4, 2025.

31

Item 6. Exhibit Index
Incorporated by reference
Exhibit
number
Exhibit titleFormFile no.ExhibitFiling
date
Filed or
furnished
herewith
31.1X
31.2X
32.1*X
32.2*X
101
The following financial statements from the Company's Quarterly Report on Form 10-Q for the quarter ended December 28, 2024, formatted in Inline XBRL: (i) Condensed consolidated balance sheets, (ii) Condensed consolidated statements of operations and comprehensive income, (iv) Condensed consolidated statements of stockholders' equity, (v) Condensed consolidated statements of cash flows and (vi) Notes to condensed consolidated financial statements, tagged as blocks of text and including detailed tags
X
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)X
*The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and are not deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
+ Indicates a management contract or compensatory plan or arrangement.
32

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Sonos, Inc.
Date: February 6, 2025
By:
/s/ Tom Conrad
Tom Conrad
Interim Chief Executive Officer
(Principal Executive Officer)
Date: February 6, 2025
By:/s/ Saori Casey
Saori Casey
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
33

Exhibit 31.1
CERTIFICATION OF INTERIM CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Tom Conrad, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Sonos, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 6, 2025
/s/ Tom Conrad
Tom Conrad
Interim Chief Executive Officer
(Principal Executive Officer)


Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Saori Casey, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Sonos, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 6, 2025
/s/ Saori Casey
Saori Casey
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)


Exhibit 32.1
CERTIFICATION OF INTERIM CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Tom Conrad, Interim Chief Executive Officer of Sonos, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, this Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended December 28, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 6, 2025
By:/s/ Tom Conrad
Tom Conrad
Interim Chief Executive Officer
(Principal Executive Officer)


Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Saori Casey, Chief Financial Officer of Sonos, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, this Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended December 28, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 6, 2025
By:/s/ Saori Casey
Saori Casey
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

v3.25.0.1
Cover Page - shares
3 Months Ended
Dec. 28, 2024
Jan. 25, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 28, 2024  
Document Transition Report false  
Entity File Number 001-38603  
Entity Registrant Name SONOS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 03-0479476  
Entity Address, Address Line One 301 Coromar Drive  
Entity Address, City or Town Santa Barbara  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93117  
City Area Code 805  
Local Phone Number 965-3001  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol SONO  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Small Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   119,082,663
Entity Central Index Key 0001314727  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Current Fiscal Year End Date --09-27  
v3.25.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Current assets:    
Cash and cash equivalents $ 279,955 $ 169,732
Marketable Securities 47,902 51,426
Accounts receivable, net 84,786 44,513
Inventories 140,892 231,505
Prepaids and other current assets 58,991 53,910
Total current assets 612,526 551,086
Property and equipment, net 95,028 102,148
Operating lease right-of-use assets 47,935 50,175
Goodwill 82,854 82,854
Intangible assets, net    
In-process research and development 0 73,770
Other intangible assets 84,488 14,266
Deferred tax assets 9,654 10,314
Other noncurrent assets 31,120 31,699
Total assets 963,605 916,312
Current liabilities:    
Accounts payable 162,080 194,590
Accrued expenses 108,871 87,783
Accrued compensation 28,509 15,701
Deferred revenue, current 20,973 21,802
Other current liabilities 52,081 46,277
Total current liabilities 372,514 366,153
Operating lease liabilities, noncurrent 56,786 56,588
Deferred revenue, noncurrent 61,245 61,075
Deferred tax liabilities 176 60
Other noncurrent liabilities 3,757 3,816
Total liabilities 494,478 487,692
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock, $0.001 par value 125 123
Treasury stock (48,504) (17,096)
Additional paid-in capital 521,121 498,245
Accumulated deficit (697) (50,934)
Accumulated other comprehensive loss (2,918) (1,718)
Total stockholders’ equity 469,127 428,620
Total liabilities and stockholders’ equity $ 963,605 $ 916,312
v3.25.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 28, 2024
Sep. 28, 2024
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Income Statement [Abstract]    
Revenue $ 550,857 $ 612,869
Cost of revenue 309,451 330,190
Gross profit 241,406 282,679
Operating expenses    
Research and development 80,838 79,235
Sales and marketing 86,644 83,950
General and administrative 25,831 39,799
Total operating expenses 193,313 202,984
Operating income 48,093 79,695
Other income (expense), net    
Interest income 1,861 3,075
Interest expense (110) (105)
Other income (expense), net (6,029) 10,274
Total other income (expense), net (4,278) 13,244
Income before provision for (benefit from) income taxes 43,815 92,939
Provision for (benefit from) income taxes (6,422) 11,992
Net income 50,237 80,947
Net income per share attributable to common stockholders:    
Net income attributable to common stockholders: $ 50,237 $ 80,947
Basic (in USD per share) $ 0.41 $ 0.65
Diluted (in USD per share) $ 0.40 $ 0.64
Weighted-average shares used in computing net income per share attributable to common stockholders:    
Basic (in shares) 122,071,586 125,181,717
Diluted (in shares) 124,731,619 126,742,153
Total comprehensive income    
Net income $ 50,237 $ 80,947
Change in foreign currency translation adjustment (1,116) (863)
Net unrealized loss on marketable securities (84) 0
Comprehensive income $ 49,037 $ 80,084
v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Total stockholders' equity, beginning balances at Sep. 30, 2023 $ 518,657 $ 130 $ 607,345 $ (72,586) $ (12,788) $ (3,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   1 3,537      
Retirement of treasury stock   (4) (60,954) 60,959    
Stock-based compensation expense     19,358      
Repurchase of common stock, including excise tax and commission       (23,484)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (3,745)    
Net income 80,947       80,947  
Change in foreign currency translation adjustment (863)         (863)
Unrealized loss on investments 0          
Total stockholders' equity, ending balances at Dec. 30, 2023 594,409 $ 127 569,286 $ (38,856) 68,159 (4,307)
Balances, beginning of period (in shares) at Sep. 30, 2023   130,399,940        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   1,268,520        
Balances, ending of period (in shares) at Dec. 30, 2023   127,243,960        
Treasury stock, Beginning balances (in shares) at Sep. 30, 2023       (5,286,024)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Retirement of treasury stock (in shares)   (4,424,500)   (4,424,500)    
Repurchase of common stock (in shares)       (1,478,597)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (332,550)    
Treasury stock, Ending balances (in shares) at Dec. 30, 2023       (2,672,671)    
Total stockholders' equity, beginning balances at Sep. 28, 2024 428,620 $ 123 498,245 $ (17,096) (50,934) (1,718)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   2 2,409      
Retirement of treasury stock   0 (4,867) 4,867    
Stock-based compensation expense     25,334      
Repurchase of common stock, including excise tax and commission       (27,231)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (9,044)    
Net income 50,237       50,237  
Change in foreign currency translation adjustment (1,116)         (1,116)
Unrealized loss on investments (84)         (84)
Total stockholders' equity, ending balances at Dec. 28, 2024 $ 469,127 $ 125 $ 521,121 $ (48,504) $ (697) $ (2,918)
Balances, beginning of period (in shares) at Sep. 28, 2024   123,046,510        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   2,103,983        
Balances, ending of period (in shares) at Dec. 28, 2024   124,729,283        
Treasury stock, Beginning balances (in shares) at Sep. 28, 2024       (1,282,734)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Retirement of treasury stock (in shares) (421,210) (421,210)   (421,210)    
Repurchase of common stock (in shares) (1,884,654)     (1,884,654)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (658,055)    
Treasury stock, Ending balances (in shares) at Dec. 28, 2024       (3,404,233)    
v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Cash flows from operating activities    
Net income $ 50,237 $ 80,947
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 25,334 19,358
Depreciation and amortization 17,611 11,878
Provision for inventory obsolescence 1,305 5,837
Restructuring and abandonment charges 0 260
Deferred income taxes 123 (45)
Other 841 1,236
Foreign currency transaction (gain) loss 2,129 (7,388)
Changes in operating assets and liabilities:    
Accounts receivable (41,374) (12,215)
Inventories 89,308 167,641
Other assets (6,437) (12,878)
Accounts payable and accrued expenses (5,940) (7,429)
Accrued compensation 12,394 5,988
Deferred revenue 1,513 3,660
Other liabilities 9,129 18,551
Net cash provided by operating activities 156,173 275,401
Cash flows from investing activities    
Purchases of marketable securities (10,128) 0
Purchases of property and equipment (13,106) (6,077)
Maturities of marketable securities 13,900 0
Net cash used in investing activities (9,334) (6,077)
Cash flows from financing activities    
Payments for repurchase of common stock, including excise tax and commission (27,165) (23,484)
Payments for repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (9,044) (3,745)
Proceeds from exercise of common stock options 2,411 3,538
Net cash used in financing activities (33,798) (23,691)
Effect of exchange rate changes on cash and cash equivalents (2,818) 1,478
Net increase in cash and cash equivalents 110,223 247,111
Cash and cash equivalents    
Beginning of period 169,732 220,231
End of period 279,955 467,342
Supplemental disclosure    
Cash paid for interest 63 58
Cash paid for taxes, net of refunds 658 3,684
Cash paid for amounts included in the measurement of lease liabilities, net of tenant improvement reimbursements received (2,531) 2,601
Supplemental disclosure of non-cash investing and financing activities    
Purchases of property and equipment in accounts payable and accrued expenses 3,693 6,141
Right-of-use assets obtained in exchange for new operating lease liabilities 0 7,637
Excise tax on share repurchases, accrued but not paid $ 668 $ 0
v3.25.0.1
Business Overview and Basis of Presentation
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business Overview and Basis of Presentation
1. Business Overview and Basis of Presentation
Description of business
Sonos, Inc. and its wholly owned subsidiaries (collectively, "Sonos," the "Company," "we," "us" or "our") designs, develops, manufactures, and sells audio products and services. The Sonos sound system provides customers with an immersive listening experience created by the design of its speakers, headphones and components, a proprietary software platform, and the ability to stream content from a variety of sources over the customer’s wireless network or over Bluetooth.
The Company’s products are sold through third-party physical retailers, including custom installers of home audio systems, select e-commerce retailers, and its website, sonos.com. The Company’s products are distributed in over 60 countries through its wholly owned subsidiaries: Sonos Europe B.V. in the Netherlands, Beijing Sonos Technology Co. Ltd. in China, Sonos Japan GK in Japan, and Sonos Australia Pty Ltd. in Australia.
Basis of presentation and preparation
The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of September 28, 2024, has been derived from the audited consolidated financial statements of the Company.
The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, (the "Annual Report"), filed with the SEC on November 15, 2024.
In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three months ended December 28, 2024, are not necessarily indicative of the results to be expected for the full fiscal year or any other period.
The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company’s fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company’s fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The three months ended December 28, 2024 and December 30, 2023, spanned 13 weeks each. As used in this Quarterly Report on Form 10-Q, "fiscal 2025" refers to the fiscal year ending September 27, 2025, "fiscal 2024" refers to the fiscal year ended September 28, 2024, and "fiscal 2023" refers to the fiscal year ended September 30, 2023.
Use of estimates and judgments
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.
v3.25.0.1
Summary of Significant Accounting Policies
3 Months Ended
Dec. 28, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
2. Summary of Significant Accounting Policies
There have been no changes in the Company’s significant accounting policies, recently adopted accounting pronouncements, or recent accounting pronouncements pending adoption from those disclosed in the Annual Report, except as noted below.
Recent accounting pronouncements pending adoption
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This standard requires disclosure of disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, and amortization. Also required is a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. The amendments may be applied retrospectively or prospectively. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements and related disclosures.
v3.25.0.1
Financial Instruments
3 Months Ended
Dec. 28, 2024
Fair Value Disclosures [Abstract]  
Financial Instruments
3. Financial Instruments
The carrying values of the Company’s accounts receivable and accounts payable, approximate their fair values due to the short period of time to maturity or repayment. The Company utilizes the following fair value hierarchy to establish priorities of the inputs used to measure fair value:
Level 1: Quoted prices in active markets for identical assets or liabilities.
Level 2: Observable inputs other than quoted market prices included in Level 1, such as quoted prices for similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
The following table summarizes cash, cash equivalents and marketable securities by investment category as of December 28, 2024 and September 28, 2024:
December 28, 2024
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$234,980 $— $— $234,980 $234,980 $— 
Level 1:
Money market funds40,881 — — 40,881 40,881 — 
Subtotal40,881 — — 40,881 40,881 — 
Level 2:
U.S. Treasury securities51,959 50 (13)51,996 4,094 47,902 
Subtotal51,959 50 (13)51,996 4,094 47,902 
Total$327,820 $50 $(13)$327,857 $279,955 $47,902 
September 28, 2024
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$144,184 $— $— $144,184 $144,184 $— 
Level 1:
Money market funds25,548 — — 25,548 25,548 — 
Subtotal25,548 — — 25,548 25,548 — 
Level 2:
U.S. Treasury securities51,304 122 — 51,426 — 51,426 
Subtotal51,304 122 — 51,426 — 51,426 
Total$221,036 $122 $— $221,158 $169,732 $51,426 
Marketable securities
As of December 28, 2024, the Company held no securities with original maturities exceeding one year. Realized gains and losses on the sale of securities are recorded in other income (expense), net in the condensed consolidated statements of operations and comprehensive income.
There were no realized gains or losses on sales of marketable securities during the three months ended December 28, 2024. The Company does not intend to sell the securities, and it is more-likely-than-not that it will not be required to sell before recovery of their amortized cost basis. Accordingly, an allowance for credit losses was deemed unnecessary for these securities as of December 28, 2024.
Accrued interest receivable related to our marketable securities was immaterial as of December 28, 2024. No accrued interest receivables were written off during the three months ended December 28, 2024.
v3.25.0.1
Revenue and Geographic Information
3 Months Ended
Dec. 28, 2024
Revenue from Contract with Customer [Abstract]  
Revenue and Geographic Information
4. Revenue and Geographic Information
Disaggregation of revenue
Revenue is attributed to each region based on ship-to address, and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each region. Revenue by region is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Americas$324,583 $392,439 
Europe, Middle East and Africa ("EMEA")197,612 191,817 
Asia Pacific ("APAC")28,662 28,613 
Total revenue$550,857 $612,869 
Revenue is attributed to individual countries based on ship-to address and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each country. Revenue by significant countries is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
United States$294,629 $361,850 
Other countries256,228 251,019 
Total revenue$550,857 $612,869 
Revenue by product category also includes the applicable service revenue for software upgrades and cloud-based services attributable to each product category. Revenue by major product category is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Sonos speakers$467,142 $503,011 
Sonos system products60,274 84,562 
Partner products and other revenue23,441 25,296 
Total revenue$550,857 $612,869 
v3.25.0.1
Balance Sheet Components
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components
5. Balance Sheet Components
Accounts receivable, net
Accounts receivable, net consist of the following:
December 28,
2024
September 28,
2024
(In thousands)
Accounts receivable$180,272 $96,254 
Allowance for credit losses(2,790)(2,619)
Allowance for sales incentives(92,696)(49,122)
Accounts receivable, net of allowances$84,786 $44,513 
Inventories
Inventories consist of the following:
December 28,
2024
September 28,
2024
(In thousands)  
Finished goods$117,040 $199,825 
Component parts23,852 31,680 
Inventories$140,892 $231,505 
As of December 28, 2024 and September 28, 2024, inventory write-downs were $32.0 million and $33.3 million, respectively.
Property and equipment
Property and equipment net of accumulated depreciation were as follows:
December 28,
2024
September 28,
2024
(In thousands)
Property and equipment
$284,166 $280,247 
Less: accumulated depreciation
(189,138)(178,099)
Property and equipment, net$95,028 $102,148 
Intangible assets
In the first quarter of fiscal year 2025, the Company determined that the underlying project related to the in-process research and development from the acquisition of Mayht Holding BV ("Mayht") was completed. As a result, the acquired $73.8 million of in-process research and development was reclassified as definite-lived developed technology and will amortize over its estimated economic life of 7 years. The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:
December 28, 2024
Gross Carrying Amount
Accumulated Amortization
Foreign Currency TranslationNet Carrying ValueWeighted-Average Remaining
Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name$451 $(206)$(10)$235 3.25
Technology-based94,419 (10,166)— 84,253 6.46
Total intangible assets$94,870 $(10,372)$(10)$84,488 6.45
September 28, 2024
Gross Carrying AmountAccumulated Amortization Foreign Currency Translation Net Carrying ValueWeighted-Average Remaining Life
(In thousands, except weighted-average remaining life)
Trade name
$451 $(188)$$270 3.50
Technology-based31,480 (17,484)13,996 4.52
Total finite-lived intangible assets31,931 (17,672)14,266 4.51
In-process research and development not subject to amortization
73,770 — 73,770 
Total intangible assets$105,701 $(17,672)$$88,036 
The following table summarizes the estimated future amortization expense of the Company's intangible assets as of December 28, 2024:
Fiscal years endingFuture Amortization Expense
(In thousands)
Remainder of fiscal 2025$9,154 
202613,576 
202713,561 
202813,446 
202912,453 
2030 and thereafter22,298 
Total future amortization expense$84,488 
Cloud Computing Arrangements
Capitalized costs to implement cloud computing arrangements net of accumulated amortization are reported as a component of other noncurrent assets on the Company's condensed consolidated balance sheets and were as follows:
December 28,
2024
September 28,
2024
(In thousands)
Cloud computing implementation costs$26,087 $25,038 
Less: accumulated amortization(10,569)(9,697)
Cloud computing implementation costs, net$15,518 $15,341 
Amortization expense for implementation costs for cloud-based computing arrangements for the three months ended December 28, 2024 and December 30, 2023 was $0.9 million.
Accrued expenses
Accrued expenses consisted of the following:
December 28,
2024
September 28,
2024
(In thousands)
Accrued inventory and supply chain costs$48,025 $34,204 
Accrued taxes28,048 19,084 
Accrued advertising and marketing18,905 12,893 
Accrued general and administrative expenses7,911 10,870 
Accrued product development3,045 4,338 
Other accrued payables2,937 6,394 
Total accrued expenses$108,871 $87,783 
Deferred revenue
Amounts invoiced in advance of revenue recognition are recorded as deferred revenue on the condensed consolidated balance sheets. For the three months ended December 28, 2024 and December 30, 2023, deferred revenue included revenue allocated to unspecified software upgrades and cloud-based services of $81.6 million and $85.3 million, respectively, as well as current deferred revenue related to newly launched products sold to resellers not recognized as revenue until the date of general availability was reached.
The following table presents the changes in the Company’s deferred revenue:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Deferred revenue, beginning of period$82,877 $80,838 
Recognition of revenue included in beginning of period deferred revenue(8,221)(4,023)
Revenue deferred, net of revenue recognized on contracts in the respective period7,562 9,090 
Deferred revenue, end of period$82,218 $85,905 
The Company expects the following recognition of deferred revenue as of December 28, 2024:
 For the fiscal years ending
 Remainder of 20252026202720282029 and
Beyond
Total
(In thousands)
Deferred revenue expected to be recognized$16,060 $18,589 $15,974 $12,981 $18,614 $82,218 
Other current liabilities
Other current liabilities consist of the following:
December 28,
2024
September 28,
2024
(In thousands)
Reserve for returns$27,393 $20,304 
Warranty liability10,921 10,565 
Short-term operating lease liabilities7,369 7,551 
Other 6,398 7,857 
Total other current liabilities$52,081 $46,277 
The following table presents the changes in the Company’s warranty liability:
December 28,
2024
December 30,
2023
(In thousands)
Warranty liability, beginning of period$10,565 $7,466 
Provision for warranties issued during the period5,475 5,582 
Settlements of warranty claims during the period(5,119)(4,276)
Warranty liability, end of period$10,921 $8,772 
v3.25.0.1
Debt
3 Months Ended
Dec. 28, 2024
Debt Disclosure [Abstract]  
Debt
6. Debt
On October 13, 2021, the Company entered into a Revolving Credit Agreement with JPMorgan Chase Bank, N.A., as the administrative agent, and Bank of America N.A., Morgan Stanley Senior Funding, Inc., and Goldman Sachs Bank USA as the other lenders party thereto (the "Revolving Credit Agreement"). The Revolving Credit Agreement provides for (i) a five-year senior secured revolving credit facility in the amount of up to $100.0 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general
corporate purposes. In June 2023, the Company amended the Revolving Credit Agreement, replacing prior references to LIBOR with references to SOFR as a result of the discontinuation of LIBOR. The facility may be drawn as an Alternative Base Rate Loan (at 1.00% plus an applicable margin) or Term Benchmark Loan (at the Term SOFR Rate, plus the applicable Term SOFR Adjustment ranging from 0.11% to 0.43%, plus an applicable margin (in total, "Adjusted Term SOFR")). The Company must also pay (i) an unused commitment fee ranging from 0.200% to 0.275% per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over Adjusted Term SOFR multiplied by the aggregate face amount of outstanding letters of credit. As of December 28, 2024, the Company did not have any outstanding borrowings and had $2.4 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement.
The Company’s obligations under the Revolving Credit Agreement are secured by substantially all of the Company’s assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires the Company to maintain a certain consolidated leverage ratio, and customary events of default. As of December 28, 2024, the Company was in compliance with all financial covenants under the Revolving Credit Agreement.
v3.25.0.1
Commitments and Contingencies
3 Months Ended
Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
7. Commitments and Contingencies
Commitments to suppliers
As of December 28, 2024, the Company's open purchase orders to contract manufacturers for finished goods were approximately $84 million, the majority of which are expected to be paid over the next six months. As of December 28, 2024, the Company's expected commitments to suppliers for components were in the range of $170 million to $190 million, the majority of which is expected to be paid and/or utilized by our contract manufacturers in building finished goods within the next two years. The expected commitments are subject to change as a result of fluctuations in the demand forecast, as well as ongoing negotiations with contract manufacturers and suppliers. These commitments are related to components that can be specific to Sonos products and comprised 1) indirect obligations to third-party manufacturers and suppliers, 2) the inventory owned by contract manufacturers procured to manufacture Sonos products, and 3) purchase commitments made by contract manufacturers to their upstream suppliers.
Legal proceedings
From time to time, the Company is involved in legal proceedings in the ordinary course of business, including claims relating to employee relations, business practices, and patent infringement. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations.
The Company’s Lawsuits Against Google:
On January 7, 2020, the Company filed a complaint with the U.S. International Trade Commission ("ITC") against Alphabet Inc. ("Alphabet") and Google LLC ("Google") and a counterpart lawsuit in the U.S. District Court for the Central District of California against Google. The complaint and lawsuit each allege infringement by Alphabet and Google of certain Sonos patents related to its smart speakers and related technology. The counterpart lawsuit was stayed pending completion of the ITC investigation and appeal thereof. The ITC concluded its investigation in January 2022, finding all five of the Company’s asserted patents to be valid and infringed by Google, and further finding that one redesign per patent proposed by Google would avoid infringement. The ITC issued a limited exclusion order and a cease-and-desist order with respect to Google’s infringing products. The Company and Google each appealed the ITC’s determination, which was upheld in its entirety by a panel of the appeals court. Google's petition for rehearing by the full appeals court has been denied. The stay in the counterpart lawsuit has been lifted. No trial date has been set.
On September 29, 2020, the Company filed another lawsuit against Google alleging infringement of additional Sonos patents and seeking monetary damages and other non-monetary relief. A jury trial was held in May 2023, which found one Sonos patent to be infringed and another Sonos patent not infringed, and returned an award of $32.5 million
based on a royalty rate of $2.30 per infringing unit. After trial, the court held Sonos’ patents unenforceable under the doctrine of prosecution laches and invalid as a result of amendments made during prosecution. The Company is appealing the ruling.
Google’s Lawsuits Against the Company:
On June 11, 2020, Google filed a lawsuit in the U.S. District Court for the Northern District of California against the Company alleging infringement by the Company of five Google patents and seeking monetary damages and other non-monetary relief. All five of these patents have since been found invalid or non-infringed by the Court or by the U.S. Patent and Trademark Office or have been withdrawn from the case by Google. The Court has now entered final judgment for Sonos and against Google. Google has appealed.
On August 8, 2022, Google filed two complaints with the ITC against the Company and two counterpart lawsuits in the Northern District of California against the Company, collectively alleging infringement by the Company of seven Google patents generally related to wireless charging, device setup, and voice control, and seeking monetary damages and other non-monetary relief. The counterpart lawsuits are stayed pending completion of the ITC investigations. The ITC has terminated the investigation as to one Google patent as a result of imminent expiration of that Google patent. The first ITC investigation concluded in December 2023 with a final determination of no violation by the Company. Google chose not to appeal this determination. The oral hearing in the second ITC investigation has been postponed after the administrative law judge has indicated that she will be invalidating both Google patents at issue.
Implicit
On March 10, 2017, Implicit, LLC (“Implicit”) filed a patent infringement action in the United States District Court, District of Delaware against the Company. Implicit is asserting that the Company has infringed on certain claims of two patents in this case. The Company denies the allegations. The claims at issue have been held unpatentable by the U.S. Patent and Trademark Office. Implicit has appealed this ruling, which is currently scheduled to be heard by the appeals court by mid-2025. A range of loss, if any, associated with this matter is not probable or reasonably estimable as of December 28, 2024.
The Company is involved in certain other litigation matters not listed above but does not consider these matters to be material either individually or in the aggregate at this time. The Company’s view of the matters not listed may change in the future as the litigation and events related thereto unfold.
v3.25.0.1
Stockholders' Equity
3 Months Ended
Dec. 28, 2024
Equity [Abstract]  
Stockholders' Equity
8. Stockholders' Equity
On November 15, 2023, the Board of Directors (the "Board") authorized a common stock repurchase program of up to $200.0 million. During the three months ended December 28, 2024, the Company repurchased 1,884,654 shares for an aggregate purchase price of $27.1 million and at an average price of $14.40 per share under the repurchase program. Aggregate purchase price and average price per share exclude commission and excise tax. As of January 1, 2023, the Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the condensed consolidated statements of equity. The Company had $43.9 million available for share repurchases under the repurchase program as of December 28, 2024.
Treasury stock during the three months ended December 28, 2024, included 658,055 shares withheld to satisfy employees' tax withholding requirements in connection with vesting of stock awards. Additionally, during the three months ended December 28, 2024, the Company retired 421,210 shares of treasury stock.
v3.25.0.1
Stock-based Compensation
3 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation
9. Stock-based Compensation
2018 Equity Incentive Plan
In July 2018, the Board adopted the 2018 Equity Incentive Plan (the "2018 Plan").
Stock options
The summary of the Company’s stock option activity is as follows:
Number of Options Weighted-Average Exercise PriceWeighted-Average Remaining
Contractual Term
Aggregate Intrinsic Value
(In years)(In thousands)
Outstanding at September 28, 20247,082,389$14.24 2.8$210 
Exercised(177,433)$13.60  
Forfeited / expired(137,698)$14.73  
Outstanding at December 28, 20246,767,258$14.24 2.6$5,852 
As of December 28, 2024 and September 28, 2024, all outstanding stock options have vested and the Company had no unrecognized stock-based compensation expense related to stock options.
Restricted stock units ("RSU")
Pursuant to the 2018 Plan, the Company issues RSUs to employees and directors. The summary of the Company’s RSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value
Aggregate Intrinsic Value
(In thousands)
Outstanding at September 28, 202410,763,098$14.79 $130,772 
Granted6,737,566$12.38  
Released(1,919,356)$13.79  
Forfeited(492,848)$14.04  
Outstanding at December 28, 202415,088,460$13.87 $226,629 
As of December 28, 2024 and September 28, 2024, the Company had $156.8 million and $115.4 million of unrecognized stock-based compensation expense related to RSUs, which are expected to be recognized over weighted-average periods of 2.6 and 2.4 years, respectively.
Performance stock units ("PSU")
Pursuant to the 2018 Plan, the Company has issued and may issue certain PSUs that vest on the satisfaction of service and performance conditions. The number of outstanding PSUs is based on the target number of share awards. The number of shares vested at the end of the performance period is based on achievement of performance conditions and may include adjustments to reflect the extent to which the corresponding performance goals have been achieved. The summary of the Company’s PSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value
Aggregate Intrinsic Value
(In thousands)
Outstanding at September 28, 2024684,080$18.37 $8,312 
Released(7,194)$17.54 
Performance adjustment(1)
(121,250)$21.80 
Outstanding at December 28, 2024555,636$17.63 $8,346 
(1) Represents adjustment based on actual achievement of performance-based awards.
As of December 28, 2024 and September 28, 2024, the Company had $0.1 million and $0.2 million of unrecognized stock-based compensation expense related to PSUs, which are expected to be recognized over weighted-average period of 1.5 years.
Stock-based compensation
Total stock-based compensation expense by functional category was as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Cost of revenue$1,349 $654 
Research and development13,315 8,979 
Sales and marketing5,632 3,815 
General and administrative5,038 5,910 
Total stock-based compensation expense$25,334 $19,358 
v3.25.0.1
Income Taxes
3 Months Ended
Dec. 28, 2024
Income Tax Disclosure [Abstract]  
Income Taxes
10. Income Taxes
The Company’s income tax provision and the resulting effective tax rate for interim periods is generally determined based upon its estimated annual effective tax rate ("AETR"), adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a higher or lower effective tax rate during a quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the AETR, and if the estimated AETR changes, a cumulative adjustment is made in that quarter.
The Company recorded a benefit from income taxes of $6.4 million and a provision for income taxes of $12.0 million for the three months ended December 28, 2024 and December 30, 2023, respectively, related to U.S. and non-U.S. income taxes. The negative U.S. AETR is driven by anticipated income tax expense on a forecasted U.S. book loss resulting from capitalizing research and development expense pursuant to U.S. Internal Revenue Code ("Section 174") with no corresponding deferred tax benefit.
For the three months ended December 28, 2024, the Company utilized the AETR method to calculate separate U.S. and foreign income tax provisions. Separate U.S. and foreign AETRs were calculated in accordance with US GAAP since Sonos Inc is forecasted in a full-year loss with no corresponding deferred tax benefit while all non-U.S. entities are forecasted to profitability and, unlike the prior year, small fluctuations in forecasted pre-tax income (loss) are not expected to have a material impact on the estimated U.S. AETR. For the three months ended December 30, 2023, the Company calculated its U.S. income tax provision using the discrete method as though the interim period was an annual period since minor deviations in the projected pre-tax net income (loss) in the U.S. could have resulted in a disproportionate and unreliable effective tax rate under the AETR method.
For the three months ended December 28, 2024, the Company’s tax benefit resulted from the application of a negative U.S. AETR to year-to-date U.S. pretax income offset in part by a tax provision for non-U.S. income taxes. For the three months ended December 30, 2023, the Company's U.S. income tax provision was adversely impacted by Section 174 as the Company recorded a current U.S. tax expense with no corresponding deferred tax benefit due to the valuation allowance maintained against its U.S. deferred tax assets.
For the three months ended December 28, 2024, the Company concluded that a full valuation allowance on its deferred tax assets in the U.S. continued to be appropriate considering cumulative pre-tax losses in recent years and uncertainty with respect to future taxable income. Release of the valuation allowance in the U.S. would result in a benefit to the income tax provision in the period the release is recorded, which could have a material impact on net earnings. The timing and amount of the potential valuation allowance release are subject to significant management judgment, as well as prospective earnings in the U.S.
v3.25.0.1
Net Income Per Share
3 Months Ended
Dec. 28, 2024
Earnings Per Share [Abstract]  
Net Income Per Share
11. Net Income Per Share
Basic net income per share attributable to common stockholders is calculated by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding less shares subject to repurchase. Diluted net income per share attributable to common stockholders adjusts the basic net income per share attributable to common stockholders and the weighted-average number of shares of common stock outstanding for the potentially dilutive impact of stock awards, using the treasury stock method.
The following table sets forth the computation of the Company’s basic and diluted net income per share attributable to common stockholders:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands, except share and per share data)
Numerator:
Net income attributable to common stockholders - basic and diluted
$50,237 $80,947 
Denominator:
Weighted-average shares of common stock—basic122,071,586125,181,717
Effect of potentially dilutive stock options34,490 133,009 
Effect of RSUs2,616,466 1,424,312 
Effect of PSUs9,077 3,115 
Weighted-average shares of common stock—diluted124,731,619126,742,153
Net income per share attributable to common stockholders:
Basic$0.41 $0.65 
Diluted$0.40 $0.64 
The following potentially dilutive shares were excluded from the computation of diluted net income per share attributable to common stockholders because including them would have been antidilutive:
Three Months Ended
December 28,
2024
December 30,
2023
Stock options to purchase common stock6,934,5538,300,168
Restricted stock units13,147,9229,903,792
Performance stock units7,51029,436
Total20,089,98518,233,396
v3.25.0.1
Retirement Plans
3 Months Ended
Dec. 28, 2024
Retirement Benefits [Abstract]  
Retirement Plans
12. Retirement Plans
The Company has a defined contribution 401(k) plan (the "401(k) Plan") for the Company’s U.S.-based employees, as well as various defined contribution plans for its international employees. Eligible U.S. employees may make tax-deferred contributions under the 401(k) plan but are limited to the maximum annual dollar amount allowable under the Internal Revenue Code of 1986, as amended (the "Code"). The Company matches contributions towards the 401(k) Plan and international defined contribution plans. The Company's matching contributions totaled $2.3 million and $2.6 million for the three months ended December 28, 2024 and December 30, 2023, respectively.
v3.25.0.1
Subsequent Events
3 Months Ended
Dec. 28, 2024
Subsequent Events [Abstract]  
Subsequent Events
13. Subsequent Events
On January 13, 2025, the Company announced that Patrick Spence would be stepping down as Chief Executive Officer (“CEO”) and as a member of the Board, effective immediately. In connection with Mr. Spence’s departure, the Board appointed Tom Conrad as Interim CEO and President, effective January 13, 2025. Mr. Conrad will remain a member of the Board; however he has resigned from his position as Chair and member of the Compensation, People and Diversity & Inclusion Committee of the Board in connection with his appointment as Interim CEO.
On January 13, 2025, the Company informed Maxime Bouvat-Merlin, the Company’s Chief Product Officer (“CPO”), that the Company had eliminated the CPO role, effective immediately. The Company and Mr. Bouvat-Merlin have agreed that he will remain employed by the Company as an advisor to the Interim CEO for a mutually agreed transition period.
On February 5, 2025, the Company announced a reorganization and reduction in force involving approximately 12% of its employees to improve the Company's operating model and cost structure and set the Company up for long-term success. The Company estimates that it will incur approximately $15 million to $18 million of restructuring and related charges, substantially all of which are related to employee severance and benefits costs. The Company expects to incur substantially all of the restructuring and related charges in the second quarter of fiscal 2025.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Pay vs Performance Disclosure    
Net income attributable to common stockholders: $ 50,237 $ 80,947
v3.25.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 28, 2024
shares
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Joanna Coles [Member]  
Trading Arrangements, by Individual  
Name Joanna Coles
Title member of the Company's Board of Directors
Rule 10b5-1 Arrangement Terminated true
Termination Date November 15, 2024
Expiration Date April 4, 2025
Aggregate Available 10,860
v3.25.0.1
Business Overview and Basis of Presentation (Policies)
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of presentation and preparation
The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of September 28, 2024, has been derived from the audited consolidated financial statements of the Company.
The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, (the "Annual Report"), filed with the SEC on November 15, 2024.
In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three months ended December 28, 2024, are not necessarily indicative of the results to be expected for the full fiscal year or any other period.
The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company’s fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company’s fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The three months ended December 28, 2024 and December 30, 2023, spanned 13 weeks each. As used in this Quarterly Report on Form 10-Q, "fiscal 2025" refers to the fiscal year ending September 27, 2025, "fiscal 2024" refers to the fiscal year ended September 28, 2024, and "fiscal 2023" refers to the fiscal year ended September 30, 2023.
Use of estimates and judgments
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends.
Recent accounting pronouncements pending adoption In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This standard requires disclosure of disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, and amortization. Also required is a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. The amendments may be applied retrospectively or prospectively. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements and related disclosures.
v3.25.0.1
Fair Value Measurements (Tables)
3 Months Ended
Dec. 28, 2024
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis
The following table summarizes cash, cash equivalents and marketable securities by investment category as of December 28, 2024 and September 28, 2024:
December 28, 2024
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$234,980 $— $— $234,980 $234,980 $— 
Level 1:
Money market funds40,881 — — 40,881 40,881 — 
Subtotal40,881 — — 40,881 40,881 — 
Level 2:
U.S. Treasury securities51,959 50 (13)51,996 4,094 47,902 
Subtotal51,959 50 (13)51,996 4,094 47,902 
Total$327,820 $50 $(13)$327,857 $279,955 $47,902 
September 28, 2024
Amortized CostUnrealized GainUnrealized LossEstimated Fair ValueCash and Cash EquivalentsMarketable Securities
Cash$144,184 $— $— $144,184 $144,184 $— 
Level 1:
Money market funds25,548 — — 25,548 25,548 — 
Subtotal25,548 — — 25,548 25,548 — 
Level 2:
U.S. Treasury securities51,304 122 — 51,426 — 51,426 
Subtotal51,304 122 — 51,426 — 51,426 
Total$221,036 $122 $— $221,158 $169,732 $51,426 
v3.25.0.1
Revenue and Geographic Information (Tables)
3 Months Ended
Dec. 28, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
Revenue is attributed to each region based on ship-to address, and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each region. Revenue by region is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Americas$324,583 $392,439 
Europe, Middle East and Africa ("EMEA")197,612 191,817 
Asia Pacific ("APAC")28,662 28,613 
Total revenue$550,857 $612,869 
Revenue is attributed to individual countries based on ship-to address and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each country. Revenue by significant countries is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
United States$294,629 $361,850 
Other countries256,228 251,019 
Total revenue$550,857 $612,869 
Revenue by product category also includes the applicable service revenue for software upgrades and cloud-based services attributable to each product category. Revenue by major product category is as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Sonos speakers$467,142 $503,011 
Sonos system products60,274 84,562 
Partner products and other revenue23,441 25,296 
Total revenue$550,857 $612,869 
v3.25.0.1
Balance Sheet Components (Tables)
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Accounts Receivable
Accounts receivable, net
Accounts receivable, net consist of the following:
December 28,
2024
September 28,
2024
(In thousands)
Accounts receivable$180,272 $96,254 
Allowance for credit losses(2,790)(2,619)
Allowance for sales incentives(92,696)(49,122)
Accounts receivable, net of allowances$84,786 $44,513 
Schedule of Inventories
Inventories consist of the following:
December 28,
2024
September 28,
2024
(In thousands)  
Finished goods$117,040 $199,825 
Component parts23,852 31,680 
Inventories$140,892 $231,505 
Property, plant and equipment
Property and equipment net of accumulated depreciation were as follows:
December 28,
2024
September 28,
2024
(In thousands)
Property and equipment
$284,166 $280,247 
Less: accumulated depreciation
(189,138)(178,099)
Property and equipment, net$95,028 $102,148 
Schedule of Intangible Assets The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:
December 28, 2024
Gross Carrying Amount
Accumulated Amortization
Foreign Currency TranslationNet Carrying ValueWeighted-Average Remaining
Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name$451 $(206)$(10)$235 3.25
Technology-based94,419 (10,166)— 84,253 6.46
Total intangible assets$94,870 $(10,372)$(10)$84,488 6.45
September 28, 2024
Gross Carrying AmountAccumulated Amortization Foreign Currency Translation Net Carrying ValueWeighted-Average Remaining Life
(In thousands, except weighted-average remaining life)
Trade name
$451 $(188)$$270 3.50
Technology-based31,480 (17,484)13,996 4.52
Total finite-lived intangible assets31,931 (17,672)14,266 4.51
In-process research and development not subject to amortization
73,770 — 73,770 
Total intangible assets$105,701 $(17,672)$$88,036 
Schedule of Intangible Assets The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:
December 28, 2024
Gross Carrying Amount
Accumulated Amortization
Foreign Currency TranslationNet Carrying ValueWeighted-Average Remaining
Life
(In years)
(In thousands, except weighted-average remaining life)
Trade name$451 $(206)$(10)$235 3.25
Technology-based94,419 (10,166)— 84,253 6.46
Total intangible assets$94,870 $(10,372)$(10)$84,488 6.45
September 28, 2024
Gross Carrying AmountAccumulated Amortization Foreign Currency Translation Net Carrying ValueWeighted-Average Remaining Life
(In thousands, except weighted-average remaining life)
Trade name
$451 $(188)$$270 3.50
Technology-based31,480 (17,484)13,996 4.52
Total finite-lived intangible assets31,931 (17,672)14,266 4.51
In-process research and development not subject to amortization
73,770 — 73,770 
Total intangible assets$105,701 $(17,672)$$88,036 
Summary of Estimated Future Amortization Expense
The following table summarizes the estimated future amortization expense of the Company's intangible assets as of December 28, 2024:
Fiscal years endingFuture Amortization Expense
(In thousands)
Remainder of fiscal 2025$9,154 
202613,576 
202713,561 
202813,446 
202912,453 
2030 and thereafter22,298 
Total future amortization expense$84,488 
Summary of Cloud Computing Arrangements
Capitalized costs to implement cloud computing arrangements net of accumulated amortization are reported as a component of other noncurrent assets on the Company's condensed consolidated balance sheets and were as follows:
December 28,
2024
September 28,
2024
(In thousands)
Cloud computing implementation costs$26,087 $25,038 
Less: accumulated amortization(10,569)(9,697)
Cloud computing implementation costs, net$15,518 $15,341 
Schedule of Accrued Expenses
Accrued expenses consisted of the following:
December 28,
2024
September 28,
2024
(In thousands)
Accrued inventory and supply chain costs$48,025 $34,204 
Accrued taxes28,048 19,084 
Accrued advertising and marketing18,905 12,893 
Accrued general and administrative expenses7,911 10,870 
Accrued product development3,045 4,338 
Other accrued payables2,937 6,394 
Total accrued expenses$108,871 $87,783 
Changes in Deferred Balances and Expected Revenue Recognition
The following table presents the changes in the Company’s deferred revenue:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Deferred revenue, beginning of period$82,877 $80,838 
Recognition of revenue included in beginning of period deferred revenue(8,221)(4,023)
Revenue deferred, net of revenue recognized on contracts in the respective period7,562 9,090 
Deferred revenue, end of period$82,218 $85,905 
Remaining Performance Obligation
The Company expects the following recognition of deferred revenue as of December 28, 2024:
 For the fiscal years ending
 Remainder of 20252026202720282029 and
Beyond
Total
(In thousands)
Deferred revenue expected to be recognized$16,060 $18,589 $15,974 $12,981 $18,614 $82,218 
Schedule of Other Current Liabilities
Other current liabilities consist of the following:
December 28,
2024
September 28,
2024
(In thousands)
Reserve for returns$27,393 $20,304 
Warranty liability10,921 10,565 
Short-term operating lease liabilities7,369 7,551 
Other 6,398 7,857 
Total other current liabilities$52,081 $46,277 
Schedule of Product Warranty Liability
The following table presents the changes in the Company’s warranty liability:
December 28,
2024
December 30,
2023
(In thousands)
Warranty liability, beginning of period$10,565 $7,466 
Provision for warranties issued during the period5,475 5,582 
Settlements of warranty claims during the period(5,119)(4,276)
Warranty liability, end of period$10,921 $8,772 
v3.25.0.1
Stock-based Compensation (Tables)
3 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The summary of the Company’s stock option activity is as follows:
Number of Options Weighted-Average Exercise PriceWeighted-Average Remaining
Contractual Term
Aggregate Intrinsic Value
(In years)(In thousands)
Outstanding at September 28, 20247,082,389$14.24 2.8$210 
Exercised(177,433)$13.60  
Forfeited / expired(137,698)$14.73  
Outstanding at December 28, 20246,767,258$14.24 2.6$5,852 
Schedule of Restricted Stock Unit Activity The summary of the Company’s RSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value
Aggregate Intrinsic Value
(In thousands)
Outstanding at September 28, 202410,763,098$14.79 $130,772 
Granted6,737,566$12.38  
Released(1,919,356)$13.79  
Forfeited(492,848)$14.04  
Outstanding at December 28, 202415,088,460$13.87 $226,629 
Schedule of Performance Stock Units Activity The summary of the Company’s PSU activity is as follows:
Number of Units
Weighted-Average Grant Date Fair
Value
Aggregate Intrinsic Value
(In thousands)
Outstanding at September 28, 2024684,080$18.37 $8,312 
Released(7,194)$17.54 
Performance adjustment(1)
(121,250)$21.80 
Outstanding at December 28, 2024555,636$17.63 $8,346 
(1) Represents adjustment based on actual achievement of performance-based awards.
Schedule of Stock-based Compensation Expense
Total stock-based compensation expense by functional category was as follows:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands)
Cost of revenue$1,349 $654 
Research and development13,315 8,979 
Sales and marketing5,632 3,815 
General and administrative5,038 5,910 
Total stock-based compensation expense$25,334 $19,358 
v3.25.0.1
Net Income Per Share (Tables)
3 Months Ended
Dec. 28, 2024
Earnings Per Share [Abstract]  
Schedule of Net Income (Loss) Per Share
The following table sets forth the computation of the Company’s basic and diluted net income per share attributable to common stockholders:
Three Months Ended
December 28,
2024
December 30,
2023
(In thousands, except share and per share data)
Numerator:
Net income attributable to common stockholders - basic and diluted
$50,237 $80,947 
Denominator:
Weighted-average shares of common stock—basic122,071,586125,181,717
Effect of potentially dilutive stock options34,490 133,009 
Effect of RSUs2,616,466 1,424,312 
Effect of PSUs9,077 3,115 
Weighted-average shares of common stock—diluted124,731,619126,742,153
Net income per share attributable to common stockholders:
Basic$0.41 $0.65 
Diluted$0.40 $0.64 
Schedule of Antidilutive Securities
The following potentially dilutive shares were excluded from the computation of diluted net income per share attributable to common stockholders because including them would have been antidilutive:
Three Months Ended
December 28,
2024
December 30,
2023
Stock options to purchase common stock6,934,5538,300,168
Restricted stock units13,147,9229,903,792
Performance stock units7,51029,436
Total20,089,98518,233,396
v3.25.0.1
Business Overview and Basis of Presentation (Details)
Dec. 28, 2024
country
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of countries where products distributed 60
v3.25.0.1
Financial Instruments - Cash, Cash Equivalents and Marketable Securities by Investment Category (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Dec. 30, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Cash $ 234,980   $ 144,184
Unrealized Gain 50   122
Unrealized Loss (13)   0
Total 327,820   221,036
Total 327,857   221,158
Cash and cash equivalents 279,955 $ 169,732 169,732
Marketable Securities 47,902 $ 51,426 51,426
Level 1:      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Cash equivalents 40,881   25,548
Amortized Cost 40,881   25,548
Estimated Fair Value 40,881   25,548
Level 1: | Money market funds      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Amortized Cost 40,881   25,548
Cash equivalents 40,881   25,548
Estimated Fair Value 40,881   25,548
Level 2:      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Amortized Cost 51,959   51,304
Cash equivalents 4,094   0
Unrealized Gain 50   122
Unrealized Loss (13)   0
Estimated Fair Value 51,996   51,426
Marketable Securities 47,902   51,426
Level 2: | U.S. Treasury securities      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Amortized Cost 51,959   51,304
Cash equivalents 4,094   0
Unrealized Gain 50   122
Unrealized Loss (13)   0
Estimated Fair Value 51,996   51,426
Marketable Securities $ 47,902   $ 51,426
v3.25.0.1
Financial Instruments - Narrative (Details) - USD ($)
3 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Debt Securities, Available-for-Sale [Line Items]    
Realized gain (loss) $ 0  
Accrued interest 0  
Accrued interest writeoff $ 0  
Debt Securities, Available-For-Sale, Excluding Accrued Interest, Current [Member]    
Debt Securities, Available-for-Sale [Line Items]    
Debt securities, available-for-sale, noncurrent   $ 0
v3.25.0.1
Revenue and Geographic Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Disaggregation of Revenue [Line Items]    
Revenue $ 550,857 $ 612,869
Sonos speakers    
Disaggregation of Revenue [Line Items]    
Revenue 467,142 503,011
Sonos system products    
Disaggregation of Revenue [Line Items]    
Revenue 60,274 84,562
Partner products and other revenue    
Disaggregation of Revenue [Line Items]    
Revenue 23,441 25,296
Americas    
Disaggregation of Revenue [Line Items]    
Revenue 324,583 392,439
Europe, Middle East and Africa ("EMEA")    
Disaggregation of Revenue [Line Items]    
Revenue 197,612 191,817
Asia Pacific ("APAC")    
Disaggregation of Revenue [Line Items]    
Revenue 28,662 28,613
United States    
Disaggregation of Revenue [Line Items]    
Revenue 294,629 361,850
Other countries    
Disaggregation of Revenue [Line Items]    
Revenue $ 256,228 $ 251,019
v3.25.0.1
Balance Sheet Components - Summary of Accounts Receivable (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accounts receivable $ 180,272 $ 96,254
Allowance for credit losses (2,790) (2,619)
Allowance for sales incentives (92,696) (49,122)
Accounts receivable, net of allowances $ 84,786 $ 44,513
v3.25.0.1
Balance Sheet Components - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Finished goods $ 117,040 $ 199,825
Component parts 23,852 31,680
Inventories $ 140,892 $ 231,505
v3.25.0.1
Balance Sheet Components - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Sep. 28, 2024
Business Acquisition [Line Items]      
Provision for inventory obsolescence $ 32.0   $ 33.3
Amortization expenses 0.9 $ 0.9  
Revenue recognized from previous period 81.6 $ 85.3  
Mayht Holding BV | In Process Research and Development      
Business Acquisition [Line Items]      
Provisional information, adjustment, intangibles (73.8)    
Mayht Holding BV | In Process Research and Development      
Business Acquisition [Line Items]      
Provisional information, adjustment, intangibles $ 73.8    
Finite-lived intangible asset, useful life 7 years    
v3.25.0.1
Balance Sheet Components - Schedule of Property Plant and Equipment (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Property and equipment $ 284,166 $ 280,247
Less: accumulated depreciation (189,138) (178,099)
Property and equipment, net $ 95,028 $ 102,148
v3.25.0.1
Balance Sheet Components - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 94,870 $ 31,931
Accumulated Amortization (10,372) (17,672)
Foreign Currency Translation (10) 7
Total future amortization expense $ 84,488 $ 14,266
Weighted-Average Remaining Life (In years) 6 years 5 months 12 days 4 years 6 months 3 days
Indefinite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount   $ 105,701
Foreign Currency Translation   7
Net Carrying Value   88,036
In Process Research and Development    
Indefinite-Lived Intangible Assets [Line Items]    
In-process research and development not subject to amortization   73,770
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 451 451
Accumulated Amortization (206) (188)
Foreign Currency Translation (10) 7
Total future amortization expense $ 235 $ 270
Weighted-Average Remaining Life (In years) 3 years 3 months 3 years 6 months
Technology-based    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 94,419 $ 31,480
Accumulated Amortization (10,166) (17,484)
Foreign Currency Translation 0 0
Total future amortization expense $ 84,253 $ 13,996
Weighted-Average Remaining Life (In years) 6 years 5 months 15 days 4 years 6 months 7 days
v3.25.0.1
Balance Sheet Components - Summary of Estimated Future Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Future Amortization Expense    
Remainder of fiscal 2025 $ 9,154  
2026 13,576  
2027 13,561  
2028 13,446  
2029 12,453  
2030 and thereafter 22,298  
Total future amortization expense $ 84,488 $ 14,266
v3.25.0.1
Balance Sheet Components - Summary of Cloud Computing Arrangements (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Cloud computing implementation costs $ 26,087 $ 25,038
Less: accumulated amortization (10,569) (9,697)
Cloud computing implementation costs, net $ 15,518 $ 15,341
v3.25.0.1
Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued inventory and supply chain costs $ 48,025 $ 34,204
Accrued taxes 28,048 19,084
Accrued advertising and marketing 18,905 12,893
Accrued general and administrative expenses 7,911 10,870
Accrued product development 3,045 4,338
Other accrued payables 2,937 6,394
Accrued expenses $ 108,871 $ 87,783
v3.25.0.1
Balance Sheet Components - Summary of Changes in Deferred Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Contract with Customer, Liability [Roll Forward]    
Deferred revenue, beginning of period $ 82,877 $ 80,838
Recognition of revenue included in beginning of period deferred revenue (8,221) (4,023)
Revenue deferred, net of revenue recognized on contracts in the respective period 7,562 9,090
Deferred revenue, end of period $ 82,218 $ 85,905
v3.25.0.1
Balance Sheet Components - Schedule of Expected Recognition of Deferred Revenue (Details)
$ in Thousands
Dec. 28, 2024
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 82,218
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-12-29  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 16,060
Revenue, remaining performance obligation, period 9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-09-29  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 18,589
Revenue, remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-04  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 15,974
Revenue, remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-03  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 12,981
Revenue, remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue expected to be recognized $ 18,614
Revenue, remaining performance obligation, period
v3.25.0.1
Balance Sheet Components - Schedule of Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Reserve for returns $ 27,393 $ 20,304
Warranty liability 10,921 10,565
Short-term operating lease liabilities $ 7,369 $ 7,551
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Total other current liabilities Total other current liabilities
Other $ 6,398 $ 7,857
Total other current liabilities $ 52,081 $ 46,277
v3.25.0.1
Balance Sheet Components - Schedule of Warranty Liability (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]    
Warranty liability, beginning of period $ 10,565 $ 7,466
Provision for warranties issued during the period 5,475 5,582
Settlements of warranty claims during the period (5,119) (4,276)
Warranty liability, end of period $ 10,921 $ 8,772
v3.25.0.1
Debt (Details) - Credit Facility - USD ($)
$ in Millions
1 Months Ended
Oct. 13, 2021
Jun. 30, 2023
Dec. 28, 2024
Revolving Credit Facility      
Debt Instrument [Line Items]      
Term of debt 5 years    
Maximum borrowing capacity $ 100.0    
Revolving Credit Facility | Minimum      
Debt Instrument [Line Items]      
Commitment fee percentage 0.20%    
Revolving Credit Facility | Maximum      
Debt Instrument [Line Items]      
Commitment fee percentage 0.275%    
Letter of Credit      
Debt Instrument [Line Items]      
Long-term debt     $ 2.4
Base Rate | Revolving Credit Facility      
Debt Instrument [Line Items]      
Interest rate, spread on variable rate   1.00%  
Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility | Minimum      
Debt Instrument [Line Items]      
Interest rate, spread on variable rate   0.11%  
Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility | Maximum      
Debt Instrument [Line Items]      
Interest rate, spread on variable rate   0.43%  
v3.25.0.1
Commitments and Contingencies (Details)
1 Months Ended 3 Months Ended
Aug. 08, 2022
patent
lawsuit
complaint
Jun. 11, 2020
patent
Mar. 10, 2017
patent
May 31, 2024
USD ($)
patent
Jan. 31, 2022
patent
Dec. 28, 2024
USD ($)
Lawsuits Against Google            
Loss Contingencies [Line Items]            
Gain contingency, patents found infringed upon | patent       1 5  
Amount awarded to other party       $ 32,500,000    
Royalty rate per infringing unit (in dollars per share)       $ 2.30    
Google Lawsuits Against Sonos            
Loss Contingencies [Line Items]            
Loss contingency, patents allegedly infringed upon, number | patent 7 5        
Loss contingency, patents found not infringed upon, number | patent 1 5        
Loss contingency, pending claims, number | complaint 2          
Loss contingency, number of defendants | lawsuit 2          
Implicit Against Sonos            
Loss Contingencies [Line Items]            
Loss contingency, patents allegedly infringed upon, number | patent     2      
Supply Commitment            
Loss Contingencies [Line Items]            
Commitments expected to be paid           2 years
Supply Commitment | Minimum            
Loss Contingencies [Line Items]            
Commitments to suppliers           $ 170,000,000
Supply Commitment | Maximum            
Loss Contingencies [Line Items]            
Commitments to suppliers           190,000,000
Purchase Commitment            
Loss Contingencies [Line Items]            
Purchase commitments           $ 84,000,000
Commitments expected to be paid           6 months
v3.25.0.1
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Dec. 28, 2024
Nov. 15, 2023
Equity [Abstract]    
Stock repurchase program, authorized amount   $ 200.0
Repurchase of common stock (in shares) 1,884,654  
Purchase price of common stock $ 27.1  
Average price per share (in dollars per share) $ 14.40  
Remaining authorized repurchase amount $ 43.9  
Treasury stock withheld for employees' tax withholding requirements (in shares) 658,055  
Retirement of treasury stock (in shares) 421,210  
v3.25.0.1
Stock-based Compensation - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Number of Options    
Beginning balance (in shares) 7,082,389  
Exercised (in shares) (177,433)  
Forfeited (in shares) (137,698)  
Ending balance (in shares) 6,767,258 7,082,389
Weighted-Average Grant Date Fair Value    
Beginning balance (in USD per share) $ 14.24  
Exercised (in USD per share) 13.60  
Forfeited (in USD per share) 14.73  
Ending balance (in USD per share) $ 14.24 $ 14.24
Weighted-Average Remaining Contractual Term 2 years 7 months 6 days 2 years 9 months 18 days
Aggregate Intrinsic Value $ 5,852 $ 210
v3.25.0.1
Stock-based Compensation - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 28, 2024
Jun. 29, 2024
Sep. 28, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized stock-based compensation expense $ 0   $ 0
Restricted stock units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized stock-based compensation expense $ 156,800,000   115,400,000
Unrecognized stock-based compensation expense, period of recognition 2 years 7 months 6 days 2 years 4 months 24 days  
Performance stock units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized stock-based compensation expense $ 100,000   $ 200,000
Unrecognized stock-based compensation expense, period of recognition 1 year 6 months 1 year 6 months  
v3.25.0.1
Stock-Based Compensation - Restricted Stock Unit Activity (Details) - Restricted stock units - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Number of Units    
Outstanding, beginning balance (in shares) 10,763,098  
Granted (in shares) 6,737,566  
Released (in shares) (1,919,356)  
Forfeited (in shares) (492,848)  
Outstanding, ending balance (in shares) 15,088,460  
Weighted-Average Grant Date Fair Value    
Outstanding, beginning balance (in USD per share) $ 14.79  
Granted (in USD per share) 12.38  
Released (in USD per share) 13.79  
Forfeited (in USD per share) 14.04  
Outstanding, ending balance (in USD per share) $ 13.87  
Aggregate Intrinsic Value $ 226,629 $ 130,772
v3.25.0.1
Stock-based Compensation - Performance Stock Units Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Number of Units    
Performance adjustment (in shares) (121,250)  
Weighted-Average Grant Date Fair Value    
Performance adjustment (in dollars per share) $ 21.80  
Performance stock units    
Number of Units    
Outstanding, beginning balance (in shares) 684,080  
Released (in shares) (7,194)  
Outstanding, ending balance (in shares) 555,636  
Weighted-Average Grant Date Fair Value    
Outstanding, beginning balance (in USD per share) $ 18.37  
Released (in USD per share) 17.54  
Outstanding, ending balance (in USD per share) $ 17.63  
Aggregate Intrinsic Value $ 8,346 $ 8,312
v3.25.0.1
Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 25,334 $ 19,358
Cost of revenue    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 1,349 654
Research and development    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 13,315 8,979
Sales and marketing    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 5,632 3,815
General and administrative    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 5,038 $ 5,910
v3.25.0.1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Income Tax Disclosure [Abstract]    
Provision for (benefit from) income taxes $ (6,422) $ 11,992
v3.25.0.1
Net Income Per Share - Computation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Numerator:    
Net income $ 50,237 $ 80,947
Denominator:    
Weighted-average shares of common stock - basic (in shares) 122,071,586 125,181,717
Weighted-average shares of common stock - diluted (in shares) 124,731,619 126,742,153
Net income per share attributable to common stockholders:    
Basic (in USD per share) $ 0.41 $ 0.65
Diluted (in USD per share) $ 0.40 $ 0.64
Effect of potentially dilutive stock options    
Denominator:    
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares) 34,490 133,009
Effect of RSUs    
Denominator:    
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares) 2,616,466 1,424,312
Effect of PSUs    
Denominator:    
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares) 9,077 3,115
v3.25.0.1
Net Income Per Share - Antidilutive Securities (Details) - shares
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 20,089,985 18,233,396
Stock options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 6,934,553 8,300,168
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 13,147,922 9,903,792
Performance stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities (in shares) 7,510 29,436
v3.25.0.1
Retirement Plans (Details) - USD ($)
$ in Millions
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Retirement Benefits [Abstract]    
Employer contribution $ 2.3 $ 2.6
v3.25.0.1
Subsequent Events (Details) - Subsequent Event
$ in Millions
Feb. 05, 2025
USD ($)
Subsequent Event [Line Items]  
Percent reduction in force 12.00%
Minimum  
Subsequent Event [Line Items]  
Expected restructuring cost $ 15
Maximum  
Subsequent Event [Line Items]  
Expected restructuring cost $ 18

Sonos (NASDAQ:SONO)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Sonos.
Sonos (NASDAQ:SONO)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Sonos.